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ABSTRACT
THE INTERACTION OF HOMOSERINE LACTONES AND
PARAOXONASE 2 MODULATES CELL DEATH SIGNALING AND
CELL PROLIFERATION

Aaron Mackallan Neely
February 23rd, 2017
Pseudomonas aeruginosa produces N-(3-oxododecanoyl)-homoserine lactone
(C12) as a quorum-sensing molecule that functions to facilitate bacteria-bacteria
communication. C12 has also been reported to affect many aspects of human
host cell physiology, including evoking cell death in various types of cells.
However, the signaling pathway(s) leading to C12-triggerred cell death remains
unclear. To clarify cell death signaling induced by C12, we examined mouse
embryonic fibroblasts (MEFs) deficient in one or more caspases. Our data
indicate that, unlike most apoptotic inducers, C12 evokes a novel form of
apoptosis in cells, probably through the direct induction of mitochondrial
membrane permeabilization. Importantly, C12 induces apoptosis in human
tumor cells and inhibits tumor growth in animals independent of both pro- and
anti-apoptotic Bcl-2 proteins. Previous studies indicate that C12 requires the
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lactonase/arylesterase paraoxonase 2 (PON2) to exert its cytotoxicity on MEFs.
PON2 is known to function as a lactonase to cleave C12. We found that PON2
was overexpressed in tissues from non-small cell lung carcinoma (NSCLC)
patients and oncogenically transformed human bronchia/tracheal epithelial
(NHBE) cells. Reducing PON2 expression in NSCLC cell lines as well as several
non-transformed cell lines rendered them resistant to C12. However, PON2
expression is only important for the proliferation of NSCLC cells but not that of
their untransformed counterparts, indicating that PON2 mediates apoptosis
independently of its function to modulate cell proliferation. Overall, our results
reveal a unique mitochondrial apoptotic signaling pathway triggered by
C12/PON2 interaction and PON2 plays distinct roles in apoptosis signaling and
cell proliferation.
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CHAPTER I
INTRODUCTION
Tissue differentiation and homeostasis are tightly regulated by the BcL-2
regulated cellular suicide program, apoptosis (1, 2). Many human tumor cells
acquire resistance to conventional chemotherapeutic drugs that depend on BcL-2
proteins. These neoplastic cells have been found to have an increased ratio of
anti-apoptotic to pro-apoptotic Bcl-2 proteins. Thus, the discovery of novel drugs
that are capable of overcoming apparent tumor cell BcL-2 protein dependent
resistance to cell death is a major challenge. A promising anti-tumor approach is
the identification of small molecules (as well as their cellular targets) that
preferentially trigger tumor cell apoptosis, independent of tumor cell Bcl-2 protein
profile (3, 4). While several candidate compounds have been identified, most if
not all of these drugs could only induce apoptosis independent of either antiapoptotic or pro-apoptotic Bcl-2 proteins; but not both (4-6). Conversely, the
quorum-sensing molecule N-(3-oxododecanoyl)-homoserine lactone (C12)
preferentially induces transformed cell apoptosis in vitro and inhibits transplanted
tumor growth in vivo independent of both anti- and pro-apoptotic Bcl-2 proteins,
thereby making it an ideal candidate drug. Our preliminary data indicates that
C12 triggers Bcl-2 protein-independent apoptosis, likely mediated by
Paraoxonase 2 (Pon2). PON2 is known to function as a lactonase to cleave C12.
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Previous studies indicate that C12 requires the lactonase / arylesterase PON2 to
exert its cytotoxicity (7, 8)

1.1. Programmed cell death-Apoptosis
The word Apoptosis derives from Greek origin meaning “dropping off or falling
off,” and initially referred to the process by which leaves fell from trees or petals
from flowers. Apoptosis is a biological phenomenon that consists of a
programmed sequence of biochemical events that culminate in the selective
elimination of damaged, infected and potentially neoplastic cells from the bodies
of multicellular organisms (9, 10). Apoptosis is one of the most ubiquitously
employed mechanisms by which the body disposes of cell debris or damaged
cells without eliciting localized inflammation; due to leakage of cellular
contents(11). This mode of cell death is a vital component of normal tissue
development, disease progression and maintenance of tissue homeostasis.
Additionally, it serves as a means of defense against the development and
advancement of cancer (12). The biochemical events that result in the
occurrence of Apoptosis also elicit a large number of morphological changes in
cells including cell shrinkage, blebbing of the membrane, condensation and
fragmentation of nuclear material and the formation of apoptotic bodies.

1.2. Regulation of apoptosis
Apoptosis is under stringent genetic control and can be activated by stimuli from
multiple sources. It is initiated in response to specific developmental signals or in
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the presence of various stimuli including the reduction of essential growth factors,
the activation of Tumor Necrosis Factor receptors (TNFR), DNA damage, loss of
cellular attachment, decreases in the local concentration of tissue morphogens
and major alterations in homeostatic state of the cell(13, 14).
Excess or limited apoptosis can disrupt tissue homeostasis of multicellular
organisms. When apoptosis occurs more frequently than cell proliferation does,
neurodegenerative disorders are exacerbated. Further to this, the dysregulation
of apoptosis has been implicated in the ontogeny and progression of many
disease states including many cancers and neurodegenerative disorders such as
Alzheimer’s, Huntington’s and Parkinson’s diseases (15-17). Conversely,
insufficient apoptosis can precipitate cancer development and progression (18,
19). Thus, tight regulation between apoptosis and cell proliferation is imperative
for the viability of all multicellular organisms.

1.3. Biological significance of apoptosis
Apoptosis has long been recognized as a critical regulatory component of the
development process. The role of apoptosis in development has been
investigated and well established in three organisms: Nematodes
(Caenorhabditis elegans), Fruit Flies (Drosophila melanogaster) and mouse (Mus
musculus). Apoptosis has been found to drive hemaphroditic development during
embryogenesis in C. elegans and promote the completion of development in D.
melanogaster(20). Studies have indicated that the inhibition of apoptosis elicits
developmental impediments, disorders and/or death (12, 21).
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In early mammalian development, apoptosis is instrumental in the formation of
synapses between neurons in the brain and the spinal cord as it facilitates the
removal of excess neuron cells (22). Additionally, apoptosis assists in tissue
remodeling, molding and shaping of the body and organs and the
detailing/separation of extremities (fingers and toes) by the removal of excess
tissues. Inhibition or insufficient apoptotic signaling elicits malformed limbs and
digits joined by soft tissue (Figure 1.1) (23).
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Figure 1.1. Apoptosis is required for proper development. (A) Cells between the
digits undergo apoptosis to facilitate proper finger and toe formation. (B)
Insufficient apoptosis elicits malformed digits that are joined by soft tissues
yielding the persistence of interdigital web as seen in the duck (23).
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Apoptosis is also vital in the removal of those cells that may have deleterious
effects on the organism. These include cells that are capable of participating in
an autoimmune response as well as virally infected; and thus cytotoxic, T cells
(24). Apoptosis facilitates the maintenance of tissue homeostasis. In the average
adult, billions of cells die daily via apoptosis and are then replaced with new cells
that originate from the body’s stem cell populations (25). Apoptosis regulates the
constant internal environment and normal tissue homeostasis. Under healthy and
normal conditions, the rate of cell proliferation is approximately the same as the
rate of apoptosis. This paradigm is essential for ensuring the viability of
multicellular organisms. If this balance is disrupted, such that the occurrence of
cell death is more frequent than that of cell replacement, the probability of the
onset of neurodegenerative disorders is amplified. Moreover, inadequate
apoptosis may elicit cancer development (26).

1.4. The pathways of apoptosis
Apoptosis typically occurs through one of three signaling pathways, namely the
mitochondrial (intrinsic), the death receptor (extrinsic) and the mixed pathways.

1.4.1. The intrinsic pathway of apoptosis
Intracellular death signals are translocated to the mitochondria where they induce
the mitochondria dependent intrinsic pathway of apoptosis. These signals
activate the pro-apoptotic Bcl-2 proteins, which in turn lead to the formation of
permeation channels on the outer mitochondrial membrane (OMM). These
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permeation channels facilitate the release of apoptogenic proteins (Diablo/Smac
and cytochrome c) from the mitochondrial inter-membrane space (IMS) into the
cytosol. Upon release into the cytosol, Diablo/Smac and cytochrome c induce a
cascade of caspase reactions that culminate in the occurrence of apoptosis (27).
Cytochrome c activates apoptotic protease factor 1 (apaf1), which promotes the
transition of procaspases to their active caspase form. Diablo/Smac promotes
apoptosis through direct interaction with inhibitors of apoptosis proteins (IAPs),
thereby impeding their ability to inactivate caspases (Figure 1.2) (28, 29).
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Figure1.2. The intrinsic (mitochondrial) pathway of apoptosis. Apoptotic stimuli;
such as DNA damage, elicits p53 activation. Activated p53 activates proapoptotic Bcl-2 proteins which in turn forms permeation channels on the OMM.
These permeation channels facilitate the transport of cytochrome C and
Diablo/Smac into the cytosol. While in the cytosol, cytochrome C initiates a
caspase cascade that culminates in the occurrence of apoptosis while
Diablo/Smac interacts with IAPs impeding their ability to inhibit caspases thereby
promoting apoptosis. The figure is from Dr. Mohd Saquib Khan at Pondicherry
University.
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1.4.2. The extrinsic pathway of apoptosis
In contrast to the intrinsic apoptotic pathway, death signals for extrinsic apoptotic
pathways are initiated from the outside of the cell. Induction of the extrinsic
apoptotic pathways does not involve the mitochondria, involvement of the Bcl-2
protein family or the release of cytochrome c forms the mitochondrial IMS to the
cytosol. In this pathway, specific death ligands such as tumor necrosis factor
(TNF), Fas Ligand (FasL) or TNF-related apoptosis-inducing ligand (TRAIL)
binds to their respective specific transmembrane death receptors including FAS,
tumor necrosis factor receptor 1 (TNFR1), p75, DR4(30).

The binding of death ligands to their respective specific death receptor promotes
the collection and recruitment of the adaptor protein Fas-associated death
domain (FADD) and the inactive forms of the initiator caspases 8 and 10 (procaspases 8 and 10), thus allowing for the formation of the death-inducing
signaling complex (DISC). The DISC transports the procaspase molecules in
close proximity, thereby ensuring access for their autocatalysis and eventual
release into the cytosol (31-35). Caspase 8 or 10 will then activate the effector
caspases 3/7 in a cascade precipitated by caspase-mediated reactions that will
culminate in the occurrence of apoptosis.
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Figure 1.3. The extrinsic (death receptor) pathway of apoptosis. Extrinsic
apoptotic signaling is generated extracellularly with the binding of death ligands
to specific transmembrane death receptors. Activation of death receptors elicit
clustering and recruitment of the adaptor molecule FADD, procaspase 8, 10
resulting in the formation of the DISC. DISC formation activates caspase 8, 10.
Caspase 8, 10 then activates caspase 3/6/7 and leads to apoptosis. The figure
is from Dr. Mohd Saquib Khan at Pondicherry University.
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1.4.3. The mixed pathway of apoptosis
There exist certain instances where the induction of apoptotic signaling cascades
from external sources can also elicit the activation of both intrinsic and extrinsic
apoptotic pathways. This phenomenon is known as the mixed apoptotic pathway
and entails death stimuli that are generated extracellularly causing the activation
of pro caspase 8, pro caspase 10, and formation of the DISC; in the same
manner as observed in the extrinsic apoptotic pathway. The DISC formation will
ultimately lead to autocatalysis and the eventual activation of caspase 8 and 10
(31-35). When caspase 8 is activated, it can enter one of two routes: (i) it can
activate the effector caspases 3, 6 and 7, thereby eliciting apoptosis via the
extrinsic pathway or (ii) it can enter the intrinsic apoptotic pathway via interaction
with the Bcl-2 protein family. In this instance, caspase 8 will cleave the inactive
pro-apoptotic BH3-only protein “Bid” into its truncated and active form tBid. The
tBid then activates the Bcl-2 proteins Bax and Bak at the OMM. Bak and Bax
then undergo conformational changes as well as oligomerization thereby yielding
the formation of permeation pores on the OMM. Permeation pore formation elicits
the release of cytochrome c and Diablo/Smac from the mitochondrial IMS into the
cytosol. Once in the cytosol, cytochrome c and Diablo/Smac exert their proapoptotic effects in the same fashion as they do in the intrinsic apoptotic pathway
(27, 36).

12
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Figure 1.4. The mixed pathway of apoptosis. Extracellular stimuli lead to the
formation of DISC and the subsequent activation of caspases 8 and 10. Activated
caspase 8 and 10 can cleave effector caspases to elicit cell death via the
extrinsic pathway or can enter the intrinsic pathway by interacting with Bcl-2
proteins. Caspase 8 converts Bid into tBid, which then interacts with Bax/Bak
inducing their oligomerization and formation of permeation pores on the OMM,
which facilitates the transport of apoptogenic proteins such as cytochrome c and
Diablo/Smac out of the mitochondria into the cytosol.
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1.5. Capases
The caspases and the Bcl-2 protein family are primary regulators of Apoptosis.
The caspases are a group of cysteine proteases, which cleave proteins at sites
that are proximal to aspartic acid residues(37). Caspase activation is typically
considered the molecular hallmark of apoptosis(38). Caspases exist in their
inactive forms (pro caspase), and become activated during apoptosis by proapoptotic proteins(39).

While 12 caspases have been identified to date, not all play a role in the
regulation of apoptosis. For instance, caspase 1 is instrumental in the regulation
of biological processes that are unrelated to cell death including red blood cell
and skeletal muscle myoblast maturation. In contrast, caspase 14 is critical in
skin cell development(40).

There are two classes of caspases involved in apoptosis namely the initiator
(apical) and the effector (executioner) caspases. The initiator caspases include
caspases 2, 8, 9 and 10 and are activated in response to upstream apoptotic
stimuli. The initiator caspases cleave and process the effector caspases 3, 6 and
7. Upon activation, the effector caspases trigger cell death by degrading critical
intracellular structural proteins.
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1.6. The Bcl-2 proteins
The Bcl-2 family of proteins is a major regulator of the intrinsic pathway of
apoptosis. Their names derived from B-cell lymphoma/leukemia 2, and are the
second member of a collection of proteins initially discovered during
chromosomal translocations involving chromosomes 14 and 18 in human
follicular lymphomas (41). There are approximately 20 different members of the
Bcl-2 protein family. Bcl-2 protein family members all share one to four
homologous Bcl-2 homology (BH) domains that are important for homo and
hetero-dimeric interactions among different family members. Bcl-2 proteins are
either pro-apoptotic or anti-apoptotic (1, 2, 13) depending on the amount of BH
domains and their ability to regulate apoptosis(42).

Pro-apoptotic Bcl-2 proteins are important for the initiation and stimulation of the
intrinsic apoptotic pathway. These proteins are divided into two structurally and
functionally distinct categories: multi-domain and BH3-only Bcl-2 proteins(43).
Multi-domain pro-apoptotic Bcl-2 proteins Bak, Bax and Bok share three BH
domains (BH1-BH3). They are responsible for the formation of permeation
channels on the OMM that disturbs mitochondrial membrane integrity during
apoptosis. This facilitates the release of apoptogenic proteins from the
mitochondria into the cytosol (44). Bak and Bax are ubiquitously expressed in all
tissues while Bok is present only in reproductive cells (44). Bax and Bak are
localized in different subcellular compartments of healthy cells. In the presence of
death stimuli Bax undergoes conformational changes at both the amino- and
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carboxyl- termini eliciting its translocation from the cytosol to the OMM and the
eventual formation of large oligomeric complexes. Bak is localized solely in the
mitochondria and upon apoptotic stimuli, will undergo conformational changes
elicit the formation of oligomeric complexes (45, 46). The oligomeric form of Bax
and Bak form permeation pores on the OMM (47). These permeation channels
mediate the release of pro-apoptotic proteins cytochrome c and Smac/Diablo
from the IMS of the mitochondria to the cytosol where they exert their effects.

1.7. Other cell death modalities - Autophagy and Necrosis
Autophagy is a tightly regulated, ordered cell death process. It is self-degradative
and essential for the maintenance of the balance of sources of energy at critical
stages of development as well as in response to nutrient deprivation(48).
Autophagy is also responsible for the removal of damaged organelles, misfolded
and aggregated proteins(49) and the elimination of intracellular pathogens(50).
The deregulation of autophagy has been implicated in non-apoptotic cell death.
Autophagy can be selective or non-selective in the removal of specific
organelles, ribosomes and protein aggregates(51). Furthermore, autophagy
promotes cellular senescence and cell surface antigen presentation. It protects
against genomic instability and is critical in the prevention of necrosis(50). Thus,
autophagy has a key role in the prevention of diseases including cancer,
neurodegeneration, liver diseases, autoimmune diseases, cardiomyopathy and
infections. Increased endocytosis, vacuolation, membrane blebbing and nuclear
condensation are all characteristic morphological hallmarks of autophagy. This
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type of cell death is categorized as a defensive reaction that can elicit cell death
or cell survival(50).

Another modality of cell death is necrosis. Necrosis is the irreversible loss of
plasma membrane integrity(52). It is a form of cell injury that results in the
premature death of cells in living tissue by autolysis. This type of cell death lacks
the features of apoptosis and autophagy, and typically is considered uncontrolled
(52, 53). Necrosis is typically connected to immoderate cell loss in human
pathologies and can lead to local inflammation (54-56), thought to occur through
the liberation of factors from dead cells that alert the innate immune system (53,
54, 57). Necrosis is signaled by irreversible cytoplasmic alterations
(condensation, fragmentation and loss of structure) and nuclear changes
(pyknosis, karyolysis and karyorhexis) (52, 53). Infection, toxins and trauma can
result in the unregulated digestion of cell components leading to necrosis.

1.8. N-(3-oxododecanoyl)-homoserine lactone (C12)
The gram-negative opportunistic bacterium Pseudomonas aeruginosa produces
N-(3-oxododecanoyl)-homoserine lactone (C12) as a quorum-sensing molecule
used to facilitate bacteria-bacteria communication (6). Quorum sensing is a
bacterial communication system that releases and detects small diffusible
autoinducers (7, 58). This system is responsible for the regulation of bacterial
gene expression in response to changes in cell population density(58). Gram
positive and gram-negative bacteria employ quorum-sensing communication to
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regulate a variety of physiological functions including: symbiosis, antibiotic
production, conjugation, motility and biofilm formation(58). Mounting data has
shown that C12 is involved in the regulation of bacterial virulence genes and also
interacts with eukaryotic cells (59, 60). As a small, lipid-soluble and diffusible
molecule, C12 readily enters cells of multiple tissues in the lungs of cystic fibrosis
patients including fibroblasts, epithelial cells, leukocytes, and endothelial cells
(8). Additionally C12 alters many aspects of eukaryotic cell physiology including
the inhibition of the secretion of proinflammatory cytokines (61-64), activation of
p53, and inhibition of events commonly associated with cell death (65-68). C12
has been shown to induce apoptosis in multiple types of cancer cells (66, 69-71).
C12 induces apoptosis by inhibiting phosphatidylinositide3-kinases, arresting
Akt/PKB pathway and attenuating STAT3 activity in breast carcinoma cells (7,
66). In pancreatic carcinoma cells, C12 induces apoptotic signaling and inhibits
cell migration (7, 70). In colorectal cancer cells, C12 reduces the expression of
thymidylate synthase while enhancing the activity of otherwise conventional
chemotherapeutic agents including 5-fluorouracil (5-FU) (69).

Comparative SAR analysis has indicated that long acyl side chains with a 3-oxo
substitution are essential for C12’s anti-cancer effect (69). However, the exact
signaling pathway(s) leading to C12-triggered cell death remains unclear. Our
preliminary studies indicate that C12-triggered tumor cell apoptosis occurs by
selectively activating the mitochondria-specific intrinsic pathway through a novel
mechanism that is independent of activities of both anti- and pro-apoptotic Bcl-2
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proteins in human tumor cells. We also find that C12 induces apoptosis
preferentially in oncogenically transformed but not in non-transformed human
bronchial epithelial cells. Importantly, we discovered that C12 cytotoxicity is
mediated through the lactonase activity of paraoxonase 2 (PON2).

1.9. Paraoxonase 2 (PON2)
PON2 is a ubiquitously expressed mammalian protein with anti-oxidant
properties and lactonase/arylesterase activities (72, 73). PON2 belongs to the
Paraoxonase family of proteins and rapidly hydrolyzes C12 to C12acid(carboxylic acid), which becomes trapped and accumulates within human
bronchial epithelial cells, particularly in mitochondria (74-77). PON2 is
upregulated in many types of cancer; including lung cancer, enabling cancer cells
to resist conventional therapeutic drugs (78, 79). PON2 and PON3 appear to
promote chemotherapeutic resistance and cell survival.
PON2 expression also prevents oxidation and inflammation, but the detailed
mechanisms remain unclear. This membrane-bound protein’s expression is
markedly elevated in several human non-small cell lung carcinoma (NSCLC) cell
lines. Mutations in the Pon2 gene may be associated with vascular disease and
a number of phenotypes related to diabetes.

It has been accepted that oxidative stress derived from the mitochondria, plays
an integral role in apoptosis thereby eliciting premature aging and cancer. Recent
studies have suggested that various types of cancer take advantage of protection
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derived from increased expression of antioxidant paraoxonase proteins.
Microarray studies have suggested an overexpression of PON2 in solid tumors
such as hepatocellular carcinomas and prostate carcinomas. Other studies have
identified PON2 as a member of a small category of upregulated genes that were
correlative with poor prognosis. Studies have shown that PON2 levels are
increased in some tumors at the protein level. Investigators observed moderate
PON2 overexpression in pancreas, liver, kidney and lung tumors and more than
10-fold upregulation of PON2 in thymus tumors and non-Hodgkins lymphomas.
cDNA arrays have shown that PON2 is ~2-4-fold overexpressed in urinary
bladder tumors, liver and kidney tissues in comparison to normal tissues.

1.10. Hypothesis and Significance of the project
1.10.1. Hypothesis and Specific Aims
N-(3-oxododecanoyl)-homoserine lactone (C12) is produced by Pseudomonas
aeruginosa to function as a quorum-sensing molecule for bacteria-bacteria
communication. As a small, lipid-soluble, diffusible molecule, C12 readily enters
various types of cells in the lungs of infected patients, including epithelial cells,
endothelial cells, fibroblasts and leukocytes, and its concentration is believed to
reach high micromolar levels in or adjacent to biofilms formed in the lung
airways. C12 has been reported to alter many aspects of human airway
epithelial cell physiology, including inhibition of proinflammatory cytokine
secretion and activation of events commonly linked with apoptotic cell death.
However, the signaling pathway of C12-triggered apoptosis is still unclear.
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Our overall hypothesis is that C12 triggers a novel form of apoptosis in
mammalian cells. We proposed the following specific aims to investigate our
hypothesis.

Specific aim 1. Investigate the detailed molecular mechanism of apoptosis
induced by C12.
C12 is known to evoke apoptotic cell death in mammalian cells. However, the
signaling pathway(s) leading to C12-triggered cell death is (are) still not
completely known. Particularly, the potential interplay between extrinsic and
intrinsic pathways and “initiator” vs “effector” caspases in C12-activated apoptotic
signaling remains unclear. To clarify cell death signaling induced by C12, we
systematically examined mouse embryonic fibroblasts (MEFs) deficient in
“initiator” caspases or “effector” caspases.

Specific aim 2. Explore the mechanism of how C12 induces tumor cell apoptosis
and inhibits tumor growth.
C12 has been reported to induce apoptosis in various types of tumor cells.
However, the detailed molecular mechanism of C12-triggerred tumor cell
apoptosis is still unclear. In addition, it is completely unknown whether C12
possesses any potential therapeutic effects in vivo. To gain insights into the
mechanism of C12-evoked tumor cell apoptosis, we evaluated the cytotoxic
effects of C12 on tumor cells in vitro, the inhibitory effects of C12 on tumor
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growth in vivo. In addition, the role of pro- and anti-apoptotic Bcl-2 in C12induced tumor cell apoptosis was systematically examined.

Specific aim 3. Investigate the prospective role of PON2 in C12 cytotoxicity and
elucidate the mechanism of PON2 regulation of lung tumor cell proliferation.
In nontransformed fibroblast cells, overexpression of Paraoxonase 2 (PON2)
promotes cytotoxicity of C12, but the role of endogenous PON2 in C12-evoked
apoptotic signaling was unclear. To further investigate the mechanism of C12triggered apoptosis in tumor cells, we studied the involvement of endogenous
PON2 in C12 cytotoxicity by stably reducing PON2 expression in human nonsmall cell lung cancer (NSCLC) cells. We also investigated the role of PON2 in
proliferation of NSCLC cells.

1.10.2. Significance of Project
The data acquired from this project elucidate a novel form of apoptosis induced
by C12 in tumor cells through inducing mitochondrial membrane permeabilization
independent of both pro- and anti-apoptotic Bcl-2 proteins. The distinctive proapoptotic feature of C12 has not been observed in any other apoptosis
paradigms, which might be attributed to the ability of C12 or its metabolite(s) to
directly permeabilize mitochondria (within minutes) by forming permeation
channels without the involvement of Bcl-2 proteins.
Furthermore, our studies show that expression of PON2 is increased in NSCLC
patient tissues, which renders NSCLC cells sensitive to C12 but resistant to
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conventional therapeutic drugs. Importantly, PON2 expression in NSCLC cells is
essential for their rapid proliferation. Therefore, C12 or compounds derived from
C12 could trigger rapid and Bcl-2 protein-independent apoptosis in PON2overespressing NSCLC tumors that are resistant to traditional therapeutic drugs,
whereas normal tissues are spared due to their lower PON2 expression. Overall,
C12 or C12 derivatives may be developed into useful therapies for NSCLC
tumors resistant to classical anti-cancer drugs due to dysregulated Bcl-2 protein
network and upregulated PON2 expression.
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CHAPTER II
N-(3-OXO-ACYL)-HOMOSERINE LACTONE INDUCES APOPTOSIS
EXCLUSIVELY THROUGH A MITOCHONDRIAL PATHWAY
2.1. INTRODUCTION
The gram-negative aerobic bacterium Pseudomonas aeruginosa is ubiquitously
present in soil, water, and vegetation, and is infectious to patients with cystic
fibrosis, cancer, burns or compromised immune systems (80). Pseudomonas
aeruginosa often infects the lungs of patients with cystic fibrosis, where they
form biofilms and eventually become antibiotic resistant (81). Like many other
bacteria, Pseudomonas aeruginosa controls these virulence properties by
communicating with each other through quorum-sensing, a system of response
and stimuli by which the bacteria constitutively generates, releases, detects and
responds to small diffusible autoinducers (58). The quorum-sensing molecule
N-(3-oxododecanoyl)-L-homoserine lactone (C12) is produced by
Pseudomonas aeruginosa and regulates bacterial LasI/rhlI and lasR/rhlR gene
networks in addition to influencing bacterial intercellular communication (82,
83). As a small, lipid-soluble and diffusible molecule, C12 readily enters various
types of cells in the lungs of infected patients, including epithelial cells,
endothelial cells, fibroblasts and leukocytes (6, 59, 84), where its concentration
is believed to reach high micromolar levels in or adjacent to biofilms formed in
the lung airways (65, 85, 86). C12 has been reported to alter many aspects of
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human airway epithelial cell physiology, including inhibition of proinflammatory
cytokine secretion and activation of events commonly linked with apoptotic cell
death; including plasma membrane blebbing, cell shrinkage, and nuclear
condensation and fragmentation, caspase activation and mitochondrial
membrane permeabilization (65, 66, 69, 87, 88).

Upon C12 exposure, the activation of diverse signaling pathways associated
with apoptosis is observed in different mammalian cells. In breast carcinoma
cells, C12 partially inhibits the Akt/PKB pathway, and the JAK/STAT pathway
likely mediates pro-apoptotic activities of C12 (66). Similarly, C12 suppresses
Akt activation by blocking Akt phosphorylation in undifferentiated intestinal
epithelial cells, and overexpression of constitutively active Akt is capable of
partially reducing C12 cytotoxicity (89).

Signaling from the endoplasmic reticulum (ER) has also been implicated in
apoptosis caused by C12. ER stress-responsive proteins inositol-requiring
enzyme 1 (IRE1 and X-Box Binding Protein 1 (XBP1) are required for C12induced killing of mouse embryonic fibroblasts (MEF) (90). Furthermore,
apoptosis-like morphological changes in the ER and mitochondria are observed
in bone marrow-derived macrophages upon C12 treatment (91), and
phosphorylation of mitogen-activated protein kinase p38 and eukaryotic
translation initiation factor 2 (eIF2) are two biochemical markers indicative of
cellular responses to C12 (91).
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Caspase activation is commonly observed in C12-exposed cells. Caspases are
classified into two major categories: “initiator” caspases and “effector" caspases
(92), both of which are activated by C12. Serving as a marker for C12-triggered
apoptosis, activation of the effector caspase-3 has been detected in airway
epithelial cells (65), fibroblasts (68, 93), intestinal epithelial cells (89), breast
carcinoma cells (66), lymphoma cells (94), lung carcinoma cells (7), colorectal
carcinoma cells (95), and leukocytes (91, 96, 97). Activation of the “initiator”
caspases caspase-8 (65, 94, 97, 98) and caspase-9 (65, 91) has also been
reported. These data have suggested that both the extrinsic pathway initiated
at the plasma membrane and the intrinsic pathway initiated in mitochondria may
be activated.

However, the potential interplay between extrinsic and intrinsic pathways and
“initiator” vs “effector” caspases in C12-activated apoptotic signaling remain
unclear. In this aim, MEFs deficient in one or more caspases were investigated
to elucidate the cell death signaling induced by C12. Our data indicate that C12
selectively triggers an apoptotic-signaling pathway in which C12 appears to act
by permeabilizing mitochondria, leading to activation of apoptosis.
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2.2. MATERIALS AND METHODS
2.2.1. Reagents
N-(3-oxododecanoyl)-homoserine lactone (C12), desferrioxamine (DFO),
hydrogen peroxide (H2O2), cycloheximide, etoposide and actinomycin D were
purchased from Sigma (St. Louis, MO). Propidium iodide (PI) was obtained
from Thermo (Waltham, MA). Recombinant human TNF-α was purchased from
Peprotech (Rocky Hill, NJ). The Smac mimetic TL-32711 was purchased from
Active Biochem (Maplewood, NJ). Unless otherwise stated, all reagents were
dissolved in dimethyl sulfoxide (DMSO). Dulbecco’s Modified Eagle’s Medium
(DMEM), penicillin/streptomycin, trypsin, and L-glutamine were obtained from
Mediatech (Manassas, VA), and fetal bovine serum (FBS) was purchased from
Gemini (Broderick, CA). Caspase-Glo assay 3/7 kit was purchased from
Promega (Madison, WI). Antibodies (Abs) used for western blot analysis were
anti-β-actin mAb (Sigma), anti-full-length-caspase-3 pAb; anti-full-lengthcaspase-7 pAb; anti- full-length-caspase-8 pAb; anti- full-length-caspase-9 pAb;
anti-cleaved-caspase-3 pAb; anti-cleaved-caspase-7 pAb; anti-PARP pAb (Cell
signaling; Danvers, MA),), anti-cytochrome c mAb for western blot (Santa Cruz;
Dallas, TX), anti-cytochrome c mAb for immunofluorescence staining (BD
Transduction Laboratory; San Jose, CA), anti-Tom40 pAb (Santa Cruz), antiTom20 pAb (a gift from Dr. Brian Wattenberg), peroxidase-conjugated goat antirabbit IgG (Thermo) and peroxidase-conjugated goat anti-mouse IgG (Thermo).
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2.2.2. Cell lines and cell culture
Immortalized mouse embryonic fibroblasts (MEFs) deficient in the expression of
caspase-8 and their wild-type counterparts were provided by Professor David
Vaux (Walter and Eliza Hall Institute of Medical Research, Parkville, VIC
Australia). MEFs lacking caspase-9 and their wild-type counterparts were
obtained from Professor Jerry Adams (Walter and Eliza Hall Institute of Medical
Research). MEFs lacking caspase-3, caspase-7, caspase-3 and caspase-7, or
their wild-type counterparts were obtained from Professor Richard Flavell (Yale
University). Human colorectal carcinoma HCT116 and human pancreatic
carcinoma Panc-1 were purchased from ATCC (Manassas, VA). To generate
HCT116 and Panc-1 cells with reduced caspase-8 expression or vector control,
cells were first infected by caspase-8 shRNA lentiviral particles or control
shRNA lentiviral particles with 10 µg/ml polybrene (Santa Cruz). Stable cells
were obtained by culturing cells in the medium with 5 g/ml puromycin. All of
the cell lines were grown and maintained in DMEM supplemented with 10%
FBS,100 units/ml penicillin, and 100 µg/ml streptomycin. Cells were all cultured
in a 5% CO2 humidified incubator at 37oC.

2.2.3. Cell Viability/Death Assays
MEF cell lines were plated in a 48-well tissue culture plate with 20,000 cells in
each well and cultured for 24 hours. Following treatment with different
concentrations of C12, cells were harvested in the presence of 1.0 µg/ml
propidium iodide (PI). Cell viability was measured by PI exclusion using flow
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cytometry (FACScalibur, Beckon Dickinson; San Jose, CA). The percentage of
cell death was determined as100 minus the cell viability measurement.

2.2.4. Caspase-3/7 activity
Caspase-3/7 activities were measured using a Caspase-Glo assay kit
(Promega, Madison, WI)(59). In this assay, the proluminescent substrate
containing the amino acid sequence Asp-Glu-Val-Asp (DEVD) is cleaved by
activated caspase-3/7, resulting in the release of a luciferase substrate
(aminoluciferin) and the production of luminescent signal. 24 hours before the
treatment, cells were plated in white-walled 96-well plates. At the indicated time
points following treatment with various agents, cells were mixed with CellTiterGlo reagent, and luminescence was quantified by a Gemini EM microplate
spectrofluorometer (Molecular Devices; Sunnyvale, CA) according to the
manufacturer’s protocol. Data were presented as relative luminescence units
(RLUs).

2.2.5. Western blot analysis
Equal amounts of proteins (30 µg) were separated on a 4-12% Bis-Tris gel (BioRad; Hercules, CA) and transferred onto PVDF membrane (Millipore; Billerica,
MA). The membrane was incubated with appropriate primary or secondary
antibodies either overnight at 4oC or at room temperature for 3 hours in 1X
phosphate-buffered saline (PBS) containing 5% (w/v) nonfat dry milk (Bio-Rad)
and 0.2% (v/v) Tween 20. Protein levels were detected using the enhanced
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chemiluminescent detection system (Pierce; Rockford, IL) as described
previously (99).

2.2.6. Measuring Δmito using imaging microscopy of JC1
For imaging experiments to measure mitochondrial membrane potential
(Δmito), cells were incubated with growth media containing the Δmito probe
JC1 (10 μM) for 10 minutes at room temperature, and then washed three times
with Ringer’s solution to remove the extra dye. JC1-loaded cells were placed
onto a chamber on the stage of a Nikon Diaphot inverted microscope. Cells
were maintained at room temperature during the course of the experiments.
Treatments were made by diluting stock solutions into Ringer’s solution at the
concentrations stated in the text. Fluorescence imaging evaluation of Δmito
was carried out using equipment and methods that have been reported
previously (93, 95). Briefly, a Nikon Diaphot inverted microscope with a Fluor
20 X objective (0.75 numerical aperture) was used. A charge coupled device
camera acquired JC-1 emission images (green: 510–540 nm; red: 580–620 nm)
during excitation at 490 +/- 5 nm using filter wheels (Lambda-10, Sutter
Instruments, Novato, CA). Axon Imaging Workbench 5.1 (Axon Instruments,
Foster City, CA) controlled filters and collection of data. Images were corrected
for background using regions without cells. The data were calculated with JC1
fluorescence ratios normalized to minimal JC1 ratios obtained at the beginning
of the experiment and maximal JC1 ratios acquired following 5 μM FCCP
treatment. Normalized JC1 Ratio = (Ratio at a given time - minimal Ratio) /
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(maximal ratio - minimal Ratio) * 100%. Normalized JC1 ratios at plateau
(before FCCP treatment) from at least three different experiments have been
averaged for summary graphs.

2.2.7. Immunofluorescence microscopy
MEFs plated onto cover glasses 24 hours earlier were rinsed with Ringer’s
solution and incubated for 4 hours with either vehicle (DMSO) or 50 µM C12 in
Ringer’s solution. The immunofluorescence staining of cytochrome c and
Tom20 were carried out as described previously (95). Images were captured
using a Nikon Eclipse Ti confocal microscope (Nikon; Melville, NY) equipped
with a PlanApo 60x, 1.42 NA oil immersion objective. To minimize variability for
quantitative assessment, the same microscope settings were used across
vehicle control and C12-treated samples for three individual experiments. Four
to nine fields of view were captured to acquire a sample size of at least 100
cells for each individual experiment. Intracellular distribution of cytochrome c
and TOM20 was analyzed using ImageJ (NIH). Cytochrome c release from
mitochondria was quantified by determining the standard deviation (SD) of the
mean pixel intensity of cytochrome c of each cell – this is named as the
punctate/diffuse index (100-102). Briefly, when cytochrome c is highly localized
within mitochondria, it will display a punctate distribution pattern, leading to high
SD of the average pixel intensity, but when cytochrome c is distributed
throughout the cell, the SD will be low. Therefore, a decrease in the SD
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(punctate/diffuse index) is an index of cytochrome c redistribution from
mitochondria to the cytosol.
2.2.8. Mitochondrial morphology
To image mitochondrial morphology and membrane potential using confocal
microscopy, cells were transfected with mitochondrial matrix-targeted GFP
plasmid (Clontech; Madison, WI) using an Amaxa nucleofector device (Lonza;
Allendale, NJ), seeded onto 35 mm glass coverslips and placed in a tissue
culture incubator. After 16-24 hours coverslips were mounted in a recording
chamber positioned on the stage of an inverted microscope (IX71; Olympus
America Inc., Center Valley, PA). Cells were visualized using a PlanApo 60x,
1.42 NA oil immersion objective and confocal time series images acquired using
a VT-Infinity 3 (VisiTech International; Sunderland, UK). The chamber was
perfused with Hank’s Balanced Salt Solution containing 20 nM mitochondrial
membrane potential probe tetramethylrhodamine, ethyl ester (TMRE) at room
temperature. After a 15 minute equilibration period, GFP and TMRE were
alternately excited using the 488 and 568 nm lines respectively of a KryponArgon laser. The emitted fluorescence was filtered using a dual bandpass filter
set (VisiTech International) and collected and using HCImage software
(Hamamatsu Corporation; Sewickley, PA). Mitochondrial morphology was
analyzed using ImageJ to determine the mean area/perimeter ratio and inverse
circularity as the measurement of interconnectivity and elongation respectively,
as described previously.
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2.2.9. Detection of the release of cytochrome c from mitochondria
Mitochondria were purified from MEFs as described previously (25). Isolated
mitochondria were resuspended in buffer containing 12 mM HEPES (pH 7.5),
1.7 mM Tris-HCl (pH 7.5), 100 mM KCl, 140 mM mannitol, 23 mM sucrose, 2
mM KH2PO4, 1 mM MgCl2, 0.67 mM EGTA, and 0.6 mM EDTA supplemented
with protease inhibitors (Complete; Roche Diagnostics, Indianapolis, IN). After
one hour incubation with C12 at 30°C, mitochondrial vesicles were centrifuged
at 10,000×g for 10 min and then dissolved in 1×SDS-PAGE loading buffer.
Proteins in the supernatant and pellet fractions were detected by Western
blotting.

2.2.10. Statistical analysis
All experiments were performed in triplicate at least three times. Results are
presented as mean ± standard deviation. Statistical analysis was performed
using Student’s two tail t-test. A p value < 0.05 was considered significant.
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2.3. RESULTS
2.3.1. Apoptosis is the major form of cell death caused by C12.
In multicellular organisms, cell death is a highly heterogeneous process in
which several distinct, in some cases partially overlapping, cell signaling
cascades can be activated (103). Although C12’s ability to trigger the events
commonly linked to apoptosis has been reported (65, 66, 90, 93, 96), it is
unclear whether other cell death signaling is also involved. Caspase-3 and
caspase-7 are two highly related “effector” caspases, and mouse embryonic
fibroblasts (MEFs) deficient in expression of both caspases are markedly
resistant to both mitochondrial and death receptor-mediated apoptosis (104).
To further characterize C12-induced signaling leading to cell death, we first
investigated whether caspase-3 and caspase-7 were essential to mediate
cytotoxic effects of C12. Cytotoxicity of C12 was examined in MEFs lacking
caspase-3 (caspase-3-KO), caspase-7 (caspase-7-KO), or both (caspase-3/7DKO) as well as their wild-type (WT) counterparts (Figure 2.1A). C12 induced
significant cell death in WT, caspase-3-KO and caspase-7-KO MEFs, whereas
caspase-3/7-DKO MEFs were completely resistant to C12 exposure (Figure
2.1B). Moreover, less cell death was detected in caspase-3-KO or caspase-7KO MEFs than their wild-type counterparts (Figure 2.1B). These data indicate
that both caspase-3 and caspase-7 are involved in apoptosis initiated by C12;
caspase-3 appeared to play a more prominent role than caspase-7.
Importantly, cleavage of caspase-3 and caspase-7, one of the hallmarks of
apoptosis, was detected in WT MEFs treated with C12 (Figure 2.1C).
Furthermore, a known substrate of caspase-3 and caspase-7 PARP was also
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cleaved in WT MEFs upon C12 exposure, but not in their caspase-3/7-DKO
counterparts. Overall, the essential role of caspase-3 and caspase-7 indicates
that cell death induced by C12 is largely attributed to apoptosis.
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Figure 2.1. Caspase-3 and caspase-7 are required for C12-induced cell death.
(A) The expression of caspase-3 and caspase-7 in the indicated MEFs was
examined by western blots. The molecular weight markers were labeled on the
left (kD). (B) MEFs were treated with C12 for 48 hours, and cell viability was
measured by propidium iodide exclusion. The data are presented as means ±
standard deviations of three independent experiments. Asterisks indicate P <
0.01(*); Student's unpaired t test. ns, no significance. (C) Activation of caspase3 and caspase-7 was determined by western blot. Whole cell extracts of MEFs
were acquired following 16 hour-treatment of C12. The molecular weight
markers were labeled on the left (kD).
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2.3.2. C12-induced MOMP is independent of caspase-3 and caspase-7.
Mitochondrial outer membrane permeabilization (MOMP) has been recognized
to be a “no-return” step in both intrinsic and extrinsic apoptotic pathways (105,
106). To further explore C12-initiated apoptotic signaling, we studied the
involvement of caspase-3 and caspase-7 in two key events of MOMP:
depolarization of mitochondrial membrane potential (∆mito) and release of
cytochrome c from mitochondria into the cytosol. Depolarization of Δmito was
evaluated by determining the changes in fluorescence with the voltagedependent dye JC1 being released from mitochondria into the cytosol and
nucleus. Within minutes of C12 exposure, mitochondrial Δmito in WT MEFs
became almost completely depolarized to a level close to the complete
depolarization induced by the ionophore FCCP (Figure 2.2A), consistent with
studies in other cell types (65, 95, 98). Importantly, C12 triggered similar
depolarization of Δmito in both WT and caspase-3/7-DKO MEFs (Figure 2.2B),
indicating that MOMP induced by C12 occurs upstream of “effector” caspase
activation.
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Figure 2.2. Caspase-3 and caspase-7 are not required for mitochondrial
depolarization induced by C12.
(A) MEFs from WT and caspase-3/7-DKO mice were loaded with the
mitochondrial potential dye JC-1, and fluorescence was measured using
imaging microscopy during sequential treatment with 50 M C12 and 10 M
FCCP. Typical results from three independent experiments are shown. (B)
Addition of C12 caused equivalent depolarization of mitochondrial potential in
WT and caspase-3/7-DKO MEFs. All data are shown as means ± standard
deviations of three independent experiments. Student's unpaired t test. ns, no
significance.
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2.3.3. C12-induced MOMP occurs independent and upstream of caspase-3/7
activation.
Immunofluorescence studies were used to evaluate C12-evoked redistribution
of cytochrome c from mitochondria to the cytosol and nuclei. As shown in
representative images of both WT and caspase-3/7-DKO MEFs under control
conditions, cytochrome c and the mitochondrial outer membrane protein Tom20
exhibited overlapping punctate and perinuclear distribution in cells that is typical
of mitochondrial morphology (Figure 2.3A). In addition, nuclei displayed
characteristic oval shape with smooth boundaries that largely excluded
cytochrome c and Tom20. Upon C12 treatment, distribution of cytochrome c
was diffuse in the cytosol and nuclei in both WT and caspase-3/7-DKO MEFs,
whereas Tom20 maintained its characteristic mitochondrial distribution,
demonstrating that mitochondria in WT and caspase-3/7-DKO MEFs were
permeabilized with cytochrome c released into the cytosol and diffused into the
nuclei. The redistribution of cytochrome c was quantitated by calculating the
punctate/diffuse index. These quantitative measurements showed that C12
caused equivalent cytochrome c release in WT and caspase-3/7-DKO MEFs
(Figure 2.3B), while Tom20 was still localized in mitochondria in the presence of
C12 (Figure 2.3C). Overall, these results provide more evidence that C12
triggers MOMP independent of caspase-3 and caspase-7 activation.
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Figure 2.3. C12-induced MOMP occurs upstream of caspase-3/7 activation.
(A) Representative confocal images of MEFs treated with either DMSO (control)
or 50 µM C12 for 4 hours (typical of three independent experiments. The
mitochondrial marker Tom20 is shown in red, cytochrome c in green, and DAPI
in blue. Following treatment with C12, staining of cytochrome c became diffuse
and lost its co-localization with Tom20. Arrowheads indicate cells in which
cytochrome c redistributed from mitochondria to the cytosol and nuclei. (B)
Cytochrome c is released from both WT and caspase-3/7-DKO MEFs to similar
degrees upon C12 exposure. Cytochrome c release from mitochondrial was
quantified by calculating the punctate/diffuse index, defined as the standard
deviation of the mean pixel intensity of cytochrome c staining for each cell.
Data represent means ± standard deviations of three independent experiments
with at least 100 cells in each experiment. Asterisks indicate P < 0.05 (*),
Student's unpaired t test. (C) The intracellular distribution of Tom20 was
evaluated by determining the punctate/diffuse index. Summary data show the
means ± standard deviations of the punctuate/diffuse index calculated for more
than 100 cells in 3 independent experiments. Student's unpaired t test. ns, no
significance.
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2.3.4 C12 induces apoptosis independent of caspase-8 in MEFs.
The “initiator” caspase-8 mediates extrinsic pathway initiated at the plasma
membrane, whereas the “initiator” caspase-9 is responsible for the
mitochondria-dependent intrinsic pathway (92). Activation of extrinsic and
intrinsic apoptosis pathways has been reported in cells treated with C12, but it
is not clear to what degree each pathway contributes to cell death (65, 94, 97,
107). To systematically investigate which apoptotic pathway is involved, we
first examined MEFs deficient in caspase-8 and their wild-type counterparts
(Figure 2.4A). Consistent with a previous report (108), MEFs lacking caspase-8
were resistant to the combined treatment of recombinant human TNF-α protein
and the Smac mimetic TL-32711 (Figure 2.4B). Upon exposure with C12,
similar levels of cell death (Figure 2.4C) and activated caspase-3/7 (Figure
2.4D) were detected in both WT and caspase-8-KO MEFs. Moreover, C12
triggers activation of caspase-3 and caspase-7 regardless of caspase-8
expression (Figure 2.4E). While more caspase-3 was cleaved in WT MEFs
exposed to C12, higher levels of caspase-7 activation were detected in C12treated caspase-8-KO MEFs. Similar levels of PARP cleavage was observed in
both WT and caspase-8-KO MEFs, which is in agreement with the cell death
data (Figure 2.4C).
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Figure 2.4. Caspase-8 activation is not involved in C12-induced apoptosis.
(A) Caspase-8 expression in MEFs was evaluated by western blot. (B) WT and
caspase-8-KO MEFs were cultured with the indicated combination of
recombinant human TNF-α and the Smac mimetic TL-32711. Cell viability was
determined following 24 hour-exposure by measuring propidium iodide DNA
dye exclusion. (C) The cytotoxicity of C12 on WT and caspase-8-KO MEFs
was assessed 24 hours after treatment. (D) Caspase-3/7 activities were
evaluated 24 hours after C12 treatment. (E) Upon the treatment of C12 for 12
hours, activation of caspase-3 and caspase-7 in WT and caspase-8-KO MEFs
was evaluated by western blot. The molecular weight markers were labeled on
the left (kD). All data are shown as means ± standard deviations of three
independent experiments. Asterisks indicate P < 0.01(*); Student's unpaired t
test. ns, no significance.
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2.3.5. Caspase-8 is not involved in C12-evoked human tumor cell death.
To further validate the role of caspase-8 in C12-indcued cell death, we stably
reduced caspase-8 expression in human colorectal carcinoma HCT116 and
human pancreatic carcinoma Panc-1 by shRNA (Figures 2.5A and 2.5D).
As expect, HCT116 and Panc-1 cells with reduced caspase-8 expression
exhibited resistance to the combined treatment of TNF-α and the protein
synthesis inhibitor cycloheximide (Figures 2.5B and 2.5E). In contrast, C12
caused similar levels of cell death in both HCT116 and Panc-1 cells regardless
of caspase-8 expression (Figures 2.5C and 2.5F). These data provide more
evidence that C12 induces apoptosis independent of capspase-8.
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Figure 2.5. Caspase-8 is not involved in C12-induced human tumor cell death.
(A) Caspase-8 expression in HCTT116 cells was stably reduced by shRNA.
The expression levels of caspase-8 were determined by western blot. (B)
HCT116 cells were cultured with the indicated combination of recombinant
human TNF-α protein and cycloheximide (CHX). Cell viability was determined
following 48 hour-exposure. (C) The cytotoxicity of C12 on HCT116 cells was
assessed 48 hours after C12 treatment. (D) Stable reduction of caspase-8
expression in Panc-1 cells was evaluated by western blot. (E) TNF-α protein
and cycloheximide (CHX) triggered more cell death in vector control Panc-1
cells than caspase-8 shRNA cells following 24 hour exposure. (F) C12 induced
equivalent cell death in vector-control and caspase-8-deficient Panc-1 cells
after 24 hour treatment. Data are presented as means ± standard deviations of
three independent experiments. Asterisks indicate P < 0.05 (*), Student's
unpaired t test. ns, no significance.
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2.3.6. C12 induces MOMP independent of caspase-8.
To further investigate the role of caspase-8 in C12-initiated apoptotic signaling,
we studied the involvement of caspase-8 in depolarization of ∆mito induced by
C12. Consistent with its effects on cell viability and caspase-3/7 activation,
deficiency in caspase-8 expression failed to affect the ability of C12 to induce
rapid depolarization of Δmito (Figure 2.6). These data indicate that the
caspase-8-mediated extrinsic pathway is not involved in C12-induced apoptosis
in MEFs.
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Figure 2.6. C12 induces mitochondrial membrane potential depolarization
independent of caspase-8.
(A) Mitochondrial membrane potentials of WT and caspase-8-KO MEFs loaded
with JC-1 were determined by fluorescence microscopy upon treatment with 50
M C12 and 10 M FCCP. Typical results from three independent experiments
are shown. (B) C12 caused equivalent mitochondrial depolarization in WT and
caspase-8-KO MEFs. Data are presented as means ± standard deviations of 3
independent experiments. Asterisks indicate P < 0.05 (*), Student's unpaired t
test. ns, no significance.
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2.3.7. C12 exclusively triggered mitochondria-dependent intrinsic apoptosis
pathway.
Next, we investigated whether the “initiator” caspase-9 was responsible for
C12-induced apoptosis. For this purpose, MEFs lacking caspase-9 expression
and corresponding wild-type MEFs were examined (Figure 2.7A). Two
chemotherapeutic drugs etoposide and actinomycin D known to evoke
mitochondria-dependent intrinsic apoptosis pathway only induced cell death in
wild-type but not in caspase-9-KO MEFs (Figures 2.7B-C). Unlike their wildtype counterparts, MEFs deficient in caspase-9 were completely resistant to
C12 treatment (Figure 2.7D). Importantly, C12 failed to evoke any caspase-3/7
activation in MEFs lacking caspase-9 expression (Figure 2.7E). Furthermore,
cleavage of caspase-3 and caspase-7 was only found in wild-type MEFs treated
with C12, but not in caspase-9-KO-MEFs (Figure 2.7F). Overall, these data
suggested that C12 induces apoptotic signaling largely through activating the
mitochondria-dependent intrinsic apoptotic pathway in MEFs.
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Figure 2.7. C12-induced apoptosis is dependent on caspase-9.
(A) Caspase-9 expression in MEFs was determined by western blot. (B) Wildtype and caspase-9-KO MEFs were treated for 48 hours with various
concentrations of etoposide (etop), and cell viability was measured. (C) Wildtype and caspase-9-KO MEFs were cultured with or without 0.5 g/ml
actinomycin D (actD) for 24 hours, and cell viability was evaluated. (D) Cell
viabilities of wild-type and caspase-9-KO MEFs were measured 48 hours after
treatment with different doses of C12. (E) Caspase-3/7 activities were
determined for wild-type and caspase-9-KO MEFs treated with different doses
of C12 for 24 hours. (F) Activation of caspase-3 and caspase-7 was evaluated
by western blot following 16 hour-exposure of C12. The molecular weight
markers were labeled on the left (kD). All the data are shown as means ±
standard deviations of three independent experiments. Asterisks indicate P <
0.05 (*), Student's unpaired t test. ns, no significance.
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2.3.8. C12 induced MOMP independent of caspase-9.
To further explore the roles of caspase-9 in MOMP mediated by C12, Δmito
was measured in WT and caspase-9-KO MEFs. In contrast to its effects on cell
viability and caspase-3/7 activation (Figures 2.7), deficiency in caspase-9
expression did not affect the ability of C12 to induce rapid depolarization of
Δmito (Figure 2.8), indicating that caspase-9 was not involved in C12- induced
MOMP. To further validate this notion, we examined cytochrome c
redistribution from mitochondria to the cytosol and nuclei upon C12 exposure
using immunofluorescence staining. While C12 evoked the release of
cytochrome c from mitochondria to the cytosol and nuclei regardless of
caspase-9 expression, Tom20 displayed typical punctate and perinuclear
mitochondrial distribution following C12 treatment (Figure 2.9A). Moreover,
C12 caused similar level of cytochrome c release from mitochondria in WT and
caspase-9-KO MEFs, whereas Tom20 was retained in mitochondria (Figures
2.9B-C). Taken together, these data indicated that C12 causes acute MOMP
independent of any “initiator” caspase, suggesting that the effects of C12 on
MOMP might be attributed to its direct action on mitochondria.
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Figure 2.8. C12-induced mitochondrial potential decrease is independent of
caspase-9.
(A) WT and caspase-9-KO MEFs were loaded with JC-1, and fluorescence was
measured using imaging microscopy during sequential treatment with 50 M
C12 and 10 M FCCP. Typical results from three similar experiments are
shown. (B) Summary of depolarization of Δmito in WT and caspase-9-KO
MEFs. The data are shown as means ± standard deviations of 3 independent
experiments like those in (A). Student's unpaired t test. ns, no significance.
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Figure 2.9. C12-induced caspase-9 activation occurs downstream of
mitochondrial membrane permeabilization.
(A) Representative confocal images of MEFs treated with either DMSO (control)
or 50 µM C12 for 4 hours. Tom20 is shown in red, cytochrome c in green, and
DAPI in blue. Arrow heads indicate cells with cytochrome c diffusing in the
cytosol and nuclei. (B) Summary data showing cytochrome c release upon C12
exposure. Cytochrome c release from mitochondria was quantified by
calculating the scaled punctate/diffuse index. Data are presented as mean ±
standard deviations of the punctuate/diffuse index calculated for 3 independent
experiments with at least 100 cells in each experiment. Asterisks indicate P <
0.05 (*), by Student’s unpaired t test. (C) The punctate/diffuse index of
intracellular Tom20 was calculated. The data are the means ± standard
deviations of 3 independent experiments with at least 100 cells in each
experiment. ns, no significance. Student's unpaired t test.
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2.3.9. C12 depolarizes mitochondria without influencing mitochondrial
morphology.
Changes in mitochondrial morphology during certain paradigms of apoptosis
have been associated with depolarization of mitochondria and subsequent
release of cytochrome c (109). To investigate the possible involvement of
mitochondria morphology in C12-induced mitochondrial depolarization, we
carried out experiments to evaluate mitochondrial morphology and membrane
potential using time-lapse confocal microscopy on single A549 cells. To this
purpose, fluorescent signals of GFP targeted to mitochondrial matrix and the
mitochondrial potential indicator TMRE were recorded simultaneously to
measure mitochondrial morphology and membrane potential respectively. As
shown in Figure 2.10, C12 depolarized mitochondrial potential within 10
minutes of addition to the live cells. Following an established protocol (110), we
evaluated mitochondrial morphology by measuring mitochondrial
interconnectivity and elongation. C12 did not appear to alter mitochondrial
morphology within the time window of the measurement, indicating that C12triggered mitochondrial potential depolarization occurs without changes in
mitochondrial morphology.
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Figure 2.10. C12 depolarizes mitochondrial membrane potential without
affecting mitochondrial morphology.
(A) Time-lapse confocal microscopy on single A549 cells was carried out in the
presence of the vehicle control DMSO or 100 M C12. Fluorescent signals of
mitochondrial matrix-targeted GFP and TMRE were recorded simultaneously to
evaluate mitochondrial morphology and membrane potential respectively.
Typical traces of mitochondrial area/perimeter ratio, inverse circularity, and
membrane potential of a single cell were shown. (B) Summary data (mean ±
SEM) pooled from three independent coverslips run on two separate days
depicting morphology and membrane potential at time 0 and after 10 minutes
exposure to vehicle control or C12. Asterisk indicates P < 0.05 (*) by student’s
paired t test.
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2.3.10. Lysosomes are not involved in cell death induced by C12.
There is evidence of cross-talk between mitochondria-mediated apoptosis and
lysosomal cell death (111). Given the rapid depolarization of Δmito induced by
C12, it is possible that lysosomes are involved in C12-triggerred caspaseindependent MOMP. The oxidative stress inducer hydrogen peroxide (H2O2)
has been shown to cause lysosomal membrane permeabilization (LMP) and
subsequent apoptosis, which is blocked by a highly potent iron chelator
desferrioxamine (DFO) (112, 113). Following pre-incubation with DFO, wildtype and caspase-9-KO MEF cells were treated with H2O2 and C12
respectively. As expected, both H2O2 and C12 failed to induce cell death in
capsapse-9-KO cells. Consistent with previous studies, the cell death induced
by H2O2 was markedly reduced by DFO pre-treatment (Figure 2.11A). In
contrast, DFO did not have any significant influence on cell death evoked by
C12 (Figure 2.11B), providing evidence that lysosomal cell death is unlikely
involved in C12-induced cell death.
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Figure 2.11. Lysosomal membrane permeabilization is not involved in cell death
induced by C12.
Wild-type and caspase-9-KO MEFs were cultured with or without 1 mM DFO for
2 hours. Following DFO removal, 0.7 mM H2O2 or 100 M C12 was added to
cells respectively. Cell death was measured 24 hours after H2O2 treatment (A)
or 48 hours after C12 treatment (B). Data are shown as means ± standard
deviations of three independent experiments. Asterisks indicate P < 0.05 (*),
Student's unpaired t test. ns, no significance
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2.3.11. C12 directly induces MOMP in vitro.
Since C12 depolarized Δmito starting within 1 minute and achieving complete
effect within 10-15 minutes independent of both “initiator” caspases and
“effector” caspases (Figures 2.2, 2.6 and 2.8), we reasoned that C12 could
possess activities that directly permeabilize mitochondria. To this purpose, we
examined the effects of C12 on mitochondrial outer membrane integrity in vitro.
Mitochondria isolated from WT MEFs were exposed to DMSO (control) or to 30
or 300 µM C12. We assessed the amount of cytochrome c released from the
mitochondria using western blot analysis (Figure 2.12A). In a manner
dependent on [C12], less cytochrome c was detected in mitochondrial fractions,
with concomitant increase of cytochrome c in released fractions (Figure 2.12B).
These data indicated that C12 is able to permeabilize mitochondria directly in
vitro. Overall, our data suggest that C12 evokes a mitochondrial apoptotic
signaling pathway in which C12 directly permeabilizes mitochondria, leading to
activation of apoptosis signaling (Figure 2.12C).
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Figure 2.12. C12 directly induces MOMP in vitro.
(A) Mitochondria were isolated from wild-type MEFs and incubated with C12 for
1 hour. Release of cytochrome c from mitochondria was determined by
western blot. (B) The intensities of cytochrome c in mitochondrial (P) and
cytosolic (S) fractions shown in (A) were quantified using ImageJ (NIH).
Cytochrome c release is represented as a percentage of the sum of the protein
intensity in mitochondrial and released fractions. Mean ± standard deviation for
four independent experiments are shown. Asterisks indicate P ˂ 0.01 (**) by
Student’s unpaired t test. (C) C12 permeabilizes mitochondria, subsequently
activating apoptotic-signaling pathway.
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2.4. DISCUSSION
The quorum-sensing molecule C12 evokes apoptosis in a variety of mammalian
cells (65, 66, 69, 87, 88). Several signaling pathways leading to apoptosis have
been associated with C12 cytotoxicity. In addition to activating the intrinsic
apoptosis pathway, C12 also activates caspase-8, implicating a role of the
extrinsic apoptosis cascade in C12-induced apoptosis (65, 93, 94, 97). One
possible scenario is that C12 functions as a ligand that is recognized by
receptors on the plasma membrane. However, the interplay between the
intrinsic and extrinsic pathways and the functions of key molecules involved had
not been clearly elucidated previously. In this study, we present evidence that
caspase-3/7 and caspase-9 but not caspase-8 are essential for C12-induced
apoptotic cell death, indicating that C12 selectively triggers the mitochondriadependent intrinsic apoptotic pathway. Therefore, the events associated with
activating a plasma membrane receptor are likely secondary responses to
MOMP.

In mitochondria-mediated intrinsic apoptosis signaling cascade, it is generally
believed that MOMP and cytochrome c release occur upstream of caspase-9
activation, which subsequently leads to activation of caspases-3/7(34).
However, the involvement of caspases-3/7 activation in MOMP has only been
carefully examined for limited number of apoptotic stimuli. In the study where
caspase-3/7-DKO MEFs was first reported, UV irradiation is found to trigger
intrinsic apoptosis pathway through activating caspase-3/7 (104). Unlike their
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wild-type counterparts, cells deficient in caspase-3/7 expression maintain their
Δmito upon UV irradiation. This result provides evidence that caspase-3/7
could regulate the initial phase of intrinsic apoptosis signaling in certain
apoptotic paradigms, raising the possibility of existing a feedforward loop
among MOMP, caspase-9 activation and caspase3/7 activation. In contrast,
our studies provide unequivocal evidence that C12 evokes MOMP independent
of both “initiator” and “effector” caspases. The dispensable roles of caspases in
C12-induced MOMP suggest that C12 may exert its pro-apoptotic effect without
the involvement of signaling upstream of mitochondria.

Several signaling pathways linked to apoptosis initiation, including JAK/STAT
(66), MAPK and eIF2 pathways (91) have been implicated in C12-evoked cell
death. Most of these apoptosis-associated signaling pathways are normally
involved in multiple steps of signal transduction, and the biological events
reflective of these signaling cascades are largely observed hours following C12
incubation. In contrast, depolarization of ∆mito, the earliest step of MOMP (5,
101), is always detected within minutes following C12 exposure and reaches its
maximal levels in 20 minutes (Figures 2.2, 2.6 and 2.8; also see (65, 95, 107,
114). Thus, it appears that activation of JAK/STAT, eIF2a and MAPK signaling
pathways may be secondary to MOMP initiation in the C12-triggered apoptosis
cascade.
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C12 has also been demonstrated to trigger the ER stress pathway (65, 90, 114,
115). Release of ER Ca2+ into the cytosol is observed within minutes of C12
exposure, which is implicated in C12-induced apoptosis (65, 114, 115). Since
the effects of ER stress on ∆mito occurs several hours following ER Ca2+ pool
depletion (102), the likelihood that C12-induced ER Ca2+ release directly causes
depolarization of ∆mito is low. Furthermore, recent research indicates that ER
stress-mediated apoptosis requires the pro-apoptotic Bcl-2 proteins Bak and
Bax to permeabilize mitochondria (102, 116, 117), which is inconsistent with the
evidence that C12 triggers depolarization of ∆mito independent of Bak and Bax
in various cellular systems (93, 95). Thus, it is unlikely that ER stress signaling
is directly involved in C12-mediated depolarization of ∆mito. Conceivably, C12
or its metabolite(s) acts directly on mitochondria and permeabilizes them. In
support of this notion, our in vitro studies demonstrate that C12 directly
permeabilize mitochondria (Figure 2.12).

As a lactone, C12 is known to be hydrolyzed into a carboxylic acid by
paraoxonase 2 (PON2), an enzyme with lactonase and arylesterase activities in
vitro (76). Intracellular PON2 has been demonstrated to hydrolyze C12 and
cause subsequent intracellular acidification, which is thought to mediate
biological responses to C12, such as triggering stress signaling (115). However,
the association between C12-evoked intracellular acidification and
depolarization of ∆mito remains unclear. Our previous studies demonstrated
that PON2 promotes C12-induced apoptosis in various cellular systems (95,
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114). In addition to its localization on the ER membrane and plasma membrane
(118), PON2 has been shown also to be localized in mitochondria (73). One
possibility is that PON2 cleaves C12 into a pro-apoptotic metabolite(s) that
permeabilizes mitochondria (91). C12 or a PON2-mediated derivative might
also react with other molecules (e.g. phosphorylation) in cells to generate
secondary metabolite(s) with stronger pro-apoptotic activities. Alternatively,
PON2 has anti-oxidant properties that modulate peroxidation of membrane
lipids (118) and may regulate intracellular lipid biogenesis (119, 120), which
might affect mitochondrial outer membrane lipid composition in such a way that
C12 preferentially inserts into mitochondria.

Whatever the molecular details of C12 action on mitochondria, our study has
shown that C12 induces a unique apoptotic signaling pathway in which C12 or
C12 metabolite(s) acts as a mitolytic molecule that acts to directly permeabilize
mitochondria, releasing cytochrome c to activate caspases 9, 3 and 7 and
subsequent downstream signaling leading to apoptosis and cell death
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CHAPTER III
N-(3-OXO-ACYL) HOMOSERINE LACTONE INHIBITS TUMOR GROWTH
INDEPENDENT OF BCL-2 PROTEINS

3.1. INTRODUCTION
Quorum sensing is a bacterial intercellular communication system that
constitutively produces, releases, and detects small diffusible autoinducers that
are similar to mammalian hormones (58). The gram-negative human pathogen
Pseudomonas aeruginosa uses N-(3-oxododecanoyl)-L-homoserine lactone
(C12) as a quorum-sensing signal (82, 83).

Recent studies have shown that C12 is not only important in regulating bacterial
virulence genes but also interacts with eukaryotic cells and modulates cell
physiology, such as triggering cell death (60). C12 has been demonstrated to
cause apoptosis in a variety of cancer cells (66, 69-71). C12 induces apoptosis
through inhibiting the phosphatidylinositide 3-kinases and Akt/PKB pathway and
diminishing STAT3 activities in breast carcinoma cells (66). In pancreatic
carcinoma cells, C12 also triggers apoptotic signaling and inhibits cell migration
(70). C12 decreases the expression of thymidylate synthase and enhances the
activity of chemotherapeutic agents, 5-fluorouracil (5- FU), Tomudex and Taxol in
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colorectal and prostate cancer cells. Recently, a derivative of C12, 3-oxo-12phenyldodecanoyl-L-homoserine lactone, has been identified as another cancer
cell growth inhibitor (69). Comparative SAR analysis demonstrates that long acyl
side chains with a 3-oxo substitution are essential for C12’s anti-cancer effect
(69). In light of its function of triggering tumor cell death, C12 displays promise as
a cancer treatment. However, detailed apoptotic signaling of C12 remain unclear.
Additionally, whether or not C12 cytotoxicity in vitro is relevant; to tumor growth in
vivo, has never been studied.

Resistance toward apoptosis is a hallmark of most, perhaps all, types of human
cancer (121, 122). Bcl-2 proteins are the major regulators of apoptotic signaling
pathways and can be classified into anti-apoptotic and pro-apoptotic groups.
Anti-apoptotic Bcl-2 proteins; such as Bcl-2, are considered to protect against
mitochondrial outer membrane permeabilization (MOMP) during apoptosis,
whereas pro-apoptotic Bcl-2 members such as Bax and Bak promote MOMP (42,
123). The expression of individual Bcl-2 proteins in different types of cancer has
been used as an independent prognostic marker (122). Studies in various human
tumors showed that loss of Bax expression, or increased expression of Bcl-2, are
associated with their resistance to chemotherapy (124-127). Accordingly, one
strategy for cancer therapy is to identify agonists that activate apoptotic pathway
independent of Bcl-2 proteins in tumor cells (128-130).
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To gain insights into the mechanism of C12-evoked tumor cell apoptosis, we
evaluated the cytotoxic effects of C12 on tumor cells in vitro, the inhibitory effects
of C12 on tumor growth in vivo and the role of pro- and anti-apoptotic Bcl-2
proteins in C12-induced apoptosis were systematically examined. C12 inhibited
the tumor growth through inducing apoptosis in a Bcl-2 protein-independent
manner. Our study reveals a unique anti-tumor function of C12, which may lead
to the development of new therapeutic agents for cancer.
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3.2. MATERIALS AND METHODS
3.2.1. Reagents
N-(3-oxododecanoyl)-homoserine lactone (C12), polybrene and actinomycin D
were purchased from Sigma (St. Louis, MO). Propidium iodide (PI), CMH2DCFDA (5-(and-6)-chloromethyl-2', 7’-dichlorodihydrofluorescein diacetate,
acetyl ester), TMRE (tetramethylrhodamine, ethyl ester) and TOTO-3 were
obtained from Invitrogen (Carlsbad, CA). Unless otherwise stated, all reagents
were dissolved in dimethyl sulfoxide (DMSO). Dulbecco’s Modified Eagle’s
Medium (DMEM), penicillin/streptomycin, trypsin, and L-glutamine were obtained
from Mediatech (Manassas, VA), and fetal bovine serum was purchased from
Gemini (Broderick, CA). Caspase-Glo assay 3/7 kit was purchased from
Promega (Madison, WI). Antibodies (Abs) for western blot were anti-β-actin mAb
(Sigma), anti-Bcl-2 mAb; anti-Bax pAb (Santa Cruz; Dallas, TX), anti-Bak pAb
(Millipore; Billerica, MA), anti-Mcl-1 pAb (Abcam; Cambridge, MA), anti-Noxa pAb
(Novus; Littleton, CO), anti-Puma pAb (ProSic; Poway, CA) peroxidaseconjugated goat anti-rabbit IgG (Thermo Fisher; Waltham, MA) and peroxidaseconjugated goat anti-mouse IgG (Thermo Fisher).

3.2.2. Plasmids
pBABE-hBcl-2-IRES-EGFP was generated by cloning human Bcl-2 cDNA into
pBABE-IRES-EGFP. pMIG-hMcl-1-IRES-EGFP and pMIG-hBcl-xL-IRES-EGFP
was a gift from Dr. Levi Beverly (University of Louisville). The plasmid identities
were validated by sequencing. Lentiviral human PON2 shRNA plasmid was
purchased from Santa Cruz.
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3.2.3 Retrovirus production and cell culture
Retrovirus were generated as described previously (99). HCT116 cells
expressing different levels of Bak and Bax were obtained from Dr. Richard Youle
(National Institutes of Health). HCT116 cells stably expressing Noxa shRNA or
the control luciferase shRNA were described previously (131). Puma-deficient
HCT116 cells were acquired from Dr. Bert Vogelstein (John Hopkins University).
NSCLC cell line A549 cells were obtained from ATCC, which were produced
from adenocarcinomic alveolar basal epithelial cells of a lung cancer patient
(132). NCI-H1299 cells were also acquired from ATCC. A549 cells expressing
Mcl-1shRNA or control scramble shRNA were described previously (133). A549
cells overexpressing Bcl-2, Bcl-xL or Mcl-1 were produced by retroviral infection
as described previously (99). NHBE cells were purchased from Lonza
(Walkersville, MD). hT/LT/Ras HBE cells were obtained from Professor Barrett
Rollins (Harvard Medical School). Lewis Lung Carcinoma cells, NCI-H1299 and
A549 cells were cultured as described previously (134). NHBE and hT/LT/Ras
cells were grown in BEGM supplemented with SingleQuots (LONZA). HCT116
cells were grown as described previously (135). Cells were all cultured in a 5%
CO2 humidified incubator at 37oC.

3.2.4 Cell death analysis and Chou-Talalay synergism assay
Cell viability was determined by propidium iodide exclusion using flow cytometry
as described previously (134). The synergistic effect of C12 and ABT-737 on cell
viability was evaluated by Chou-Talalay median dose effect assay. IC50 of C12
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and ABT-737 on NCI-H1299 or A549 was first determined. Various combinations
of C12 and ABT-737 at a constant ratio above or below their IC50 values were
added to cells. Following incubation for the indicated time, cell viability was
evaluated and Fa (fractional activity) was determined as the ratio between the
cell death levels of drug-treated cells and those of untreated control cells.
Combination index (CI) was calculated by the CompuSyn software (Biosoft,
Cambridge, UK).

3.2.5. Caspase-3/7 activity and TUNEL labeling
Caspase-3/7 activities were measured using a Caspase-Glo assay kit (Promega,
Madison, WI) as described previously (136). The proluminescent substrate
containing the amino acid sequence Asp-Glu-Val-Asp (DEVD) is cleaved by
activated caspase-3/7, leading to the release of a luciferase substrate
(aminoluciferin) and the generation of luminescent signal. Data were presented
as relative luminescent units (RLU) which were normalized to the corresponding
values of control cells as an indicator of caspase 3/7 activities. TUNEL labeling
was carried out by the Pathology Research Services Laboratory at University of
Washington. The slides were scanned by a ScanScope CS digital slide scanner
(Aperio; Vista, CA) and analyzed by ImageJ software (NIH) as described
previously (137).
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3.2.6. Measuring Δmito using imaging microscopy
Cells were incubated with 10 μM Δmito probe JC1 in growth media for 10
minutes at room temperature followed by three washes with Ringer’s solution.
Dye-loaded cells were mounted onto a chamber on the stage of a Nikon Diaphot
inverted microscope with a Fluor 20x objective (0.75 NA) at room temperature.
Treatments were made by diluting stock solutions into Ringer’s solution at the
indicated concentrations. Fluorescence imaging measurements of Δψmito were
performed as reported previously (93, 138). Briefly, a charge coupled device
camera collected JC-1 emission images using filter wheels (Lambda-10, Sutter
Instruments, Novato, CA). Images were corrected for background (region without
cells). Quantitative data are reported as JC1 fluorescence ratios normalized to
minimal JC1 ratios obtained at the start of the experiment and maximal JC1
ratios obtained after 5 μM FCCP treatment: Normalized JC1 Ratio = (Ratio at a
given time - minimal Ratio) / (maximal ratio - minimal Ratio) * 100%. Normalized
JC1 ratios at plateau (before addition of FCCP) from different experiments have
been averaged for summary charts.

3.2.7. Immunofluorescence Microscopy
For immunofluorescence staining of A549 and HCT116 cells, cells plated 24
hours earlier were incubated for 3 hours with either vehicle (DMSO) or 50 µM
C12 in Ringer’s solution. The immunofluorescence staining of cytochrome c was
carried out as described previously (134). Images were captured using a Nikon
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Eclipse Ti confocal microscope with a 40x CFI Plan Fluor objective (NA 0.6). To
minimize variability, the same microscope settings were used for all experiments.
For immunofluorescence staining of tumor sections, tumor sections (5 μm) were
treated with antigen retrieval procedure by boiling in 10% Triton x-100, then
slowly cooled down at room temperature. After incubating with the blocking buffer
(1× PBS, 0.2% Triton X-100, 5% goat serum), the slides were incubated with
antibodies against activated caspase-3 (Cell signaling) overnight at 4oC.
Following three 10-minute washes, slides were incubated with goat anti-rabbit
IgG (Alexafluor-568, Invitrogen) for 1 hour. The fluorescence was visualized by
confocal microscopy using a 40x CFI Plan Fluor objective (NA 0.6) and was
analyzed using ImageJ software (NIH) as described previously (139).

3.2.8. In vivo animal studies
For C12 toxicity studies, DMSO or C12 (25 mg/kg/day) was administered
intraperitoneally each day in 8 week-old C57BL/6 mice or in 6 week-old athymic
nude mice. All organs were collected and weighted at sacrifice.

For transplanted tumors in C57BL/6 mice, eight-week old C57BL/6 female mice
(Jackson Laboratories; Bar Harbor, ME) were inoculated subcutaneously (s.c.)
with 1×106 Lewis Lung Carcinoma cells on the right flank. Tumors were
measured daily with dull edged Vernier calipers (V = L×W 2/2). After tumor size
reached around 100 mm3, animals with size-matched tumors were divided into
control group and C12 group. DMSO or C12 was administered intraperitoneally
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each day. At the end of the experiments, tumors were excised for apoptosis
evaluation. For the study of transplanted human tumors, female athymic nude
mice (5-7 weeks) were purchased from Harlan Laboratories (Indianapolis, IN).
Wild-type HCT116 cells and Bax/Bak DKO HCT116 cells (3.0×10 7/ml), wild-type
A549 cells and Bcl-2-overexpressing A549 cells (3.0×107/ml) were resuspended
and mixed 1:1 (vol/vol) with Matrigel (BD Biosciences), then 0.1 ml mixture of
cells and Matrigel was injected s.c. on the right flank of mice. All animals with
size-matched tumors were divided into two groups (control and C12) when the
tumor size reached around 100 mm3. For HCT116 and Bax/Bak DKO HCT116
tumors, DMSO or C12 was administered intraperitoneally each day. DMSO or
etoposide (40 mg/kg/day) was administered intraperitoneally once every other
day. For wild-type A549 tumors, animals were treated with C12 for 6
times/week. For Bcl-2 over-expressing A549 cells tumors, DMSO or C12 was
administered with C12 each day. At the end of the experiments, tumors were
excised for apoptosis evaluation.

3.2.9. Statistical analysis
Results are presented as mean ± standard deviation of at least three
independent experiments. Statistical analysis was performed using Student’s
two-tail t-test. A p value < 0.05 was considered significant.
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3.3. RESULTS
3.3.1. C12 inhibits lung tumor growth and induces tumor cell apoptosis in vivo.
The cytotoxic effects of C12 on tumor cells have been reported previously (66,
69-71, 140), but whether they are selective for transformed cells was unknown.
To investigate whether oncogenic transformation influences the cytotoxicity of
C12, we studied normal human bronchia/tracheal epithelial (NHBE) and
corresponding HBE immortalized and transformed successively by telomerase,
SV40 large T antigen and activated Ras (H-ras V12) (141-144). This is a wellestablished epithelial cell malignant transformation system related to human lung
cancer. Following C12 treatment, transformed HBE exhibited higher levels of cell
death (Figure 3.1A) and caspase-3/7 activation (Figure 3.1B) compared with their
untransformed counterparts, indicating that C12 induces apoptosis preferentially
in transformed cells.

To investigate the relevance of C12 cytotoxicity on transformed cells to tumor
growth in animals, we examined the effects of C12 on the growth of established
Lewis Lung Carcinoma (LLC) tumors. As shown in Figure 1C, transplanted
tumors grew much more slowly in C12-treated mice than in vehicle-treated mice,
revealing a dose-dependent anti-tumor activity of C12 as a single agent.
To test the involvement of apoptosis in tumor growth inhibition, established LLC
tumors from mice were analyzed for caspase-3 activation through
immunofluorescence staining (Figures 3.1D-E), western blot (Figures 3.1F-G)
and TUNEL staining (Figures 3.1H-I). The percentage of TUNEL-positive cells
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and the levels of activated caspase-3 were higher in tumors from C12-treated
mice than in those of the control group, suggesting that apoptosis is involved in
the inhibitory activity of C12 in vivo.
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Figure 3.1. C12 inhibits LLC tumor growth and induces tumor cell apoptosis in
vivo in a dose-dependent fashion.
(A-B) Cytotoxicity of C12 is affected by oncogenic transformation. C12’s effects on
HBE cell viability (A) and caspase-3/7 activation (B) were examined. All data
shown are mean ± standard deviation of 3 independent experiments. Asterisk
indicates P < 0.05 (*) or P< 0.01 (**) by student's unpaired t test. (C) The inhibitory
effects of C12 on the growth of LLC tumors were studied. Tumors were measured
daily and tumor tissues were removed at the end of treatments. Data are shown as
mean ± standard deviation of tumor volumes of 7 animals in either vehicle control
or C12-treated group. Asterisk indicates P < 0.05 (*) by student’s unpaired t test.
(D) Apoptotic cells in tumor sections were detected by immunofluorescence
staining of activated caspase-3. Representative images of tumor sections are
shown. Scale bar, 50 µm. (E) The percentage of activated caspase-3 shown in (D)
was quantified using ImageJ software (NIH). Data are mean ± standard deviation
of three independent tumor sections. Asterisk indicates P< 0.01 (**) by student's
unpaired t test. (F) Expression of activated caspase-3 in tumor tissues was
analyzed by western blot. (G) The relative expression levels of activated caspase3 shown in (F) were quantified by measuring intensities of western blot signals
using ImageJ software and presented as arbitrary units. Data are mean ± standard
deviation of three independent tumor samples. Asterisk indicates P < 0.05 (*) by
student’s unpaired t test. (H) TUNEL staining of apoptotic cells in control or C12treated tumor sections. Representative images are shown. Scale bar, 60 µm. (I)
The percentage of apoptotic cells shown in (H) was quantified using ImageJ
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software. Data are mean ± standard deviation of three independent tumor
sections. Asterisk indicates P < 0.05 (*) or P< 0.01 (**) by student’s unpaired t test.
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3.3.2. C12 does not cause significant toxicity in mice.
To examine whether C12 possesses non-specific toxicity to animals, we
investigated the effects of administrating C12 to mice for extended periods of time.
No significant changes in body weight and organ weight (spleen, kidney, liver,
heart, lung) were observed for C12-treated C57BL/6 mice, showing no evidence of
significant toxicity of C12 upon administration (Figures 3.2A and 3.2C). Similarly,
C12 caused no significant change in body weight and organ weight (spleen,
kidney, liver, heart and lung) in athymic nude mice (Figures 3.2B and 3.2D).
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Figure 3.2. Administrating C12 to mice does not affect body weight and organ
weight.
(A-B) DMSO or C12 (25 mg/kg/day) was administered intraperitoneally to C57BL/6
mice (A) or athymic nude mice (B) daily. Body weights of mice were measured.
Data are mean ± standard deviation of body weights of 5 animals in each group.
(C-D) Effects of C12 on organ weights in C57BL/6 mice (C) and athymic nude
mice (D) were evaluated. Spleen, kidney, liver, heart and lung of the indicated
mice were weighed at sacrifice. Each organ weight was normalized as the
percentage of corresponding body weight. Data are mean ± standard deviation of
organ weights of 5 animals in each group.
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3.3.3. C12 and conventional therapeutic drugs induce tumor cell death
synergistically.
In order to explore the therapeutic potential of C12, we studied the combinatorial
effects of C12 and therapeutic drugs. A549 and NCI-H1299 cells were treated with
various concentrations of C12 and ABT-737, an inhibitor of Bcl-2 and Bcl-xL, at a
constant dose ratio. Cell death was measured at the indicated times, and the
combination index (CI) values were determined (Figure 3.3). As shown in figure
3C and 3F, in the range of tested drug concentrations, CI values were smaller than
1, indicating that C12 and ABT-737 exhibited synergistic cytotoxic effects on A549
cells and NCI-H1299 cells.
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Figure 3.3. C12 functions synergistically with ABT-737 to induce tumor cell death.
(A) C12 sensitized A549 cells to ABT-737 treatment. Upon treatment with different
combinations of C12 and ABT-737 for 48 hours, the percentage of cell death of
A549 cells was measured. The data depict mean ± standard deviation of three
independent experiments. (B) A549 cells were treated with the indicated
combination of C12 (10-100 µM) and ABT-737 (3.3-33.3 µM) for 48 hours, and cell
death was measured. The data represent mean ± standard deviation of triplicate
experiments. The experiments were performed independently three times. (C)
The data shown in (B) was analyzed as described in MATERIALS AND
METHODS. The values of combination index (CI) and fractional activity (Fa) were
calculated. (D) NCI-H1299 cells were treated with different combinations of C12
and ABT-737 for 48 hours, and cell viability was measured. The data are mean ±
standard deviation of three independent experiments. (E) NCI-H1299 cells were
cultured with the fixed combination of C12 (5-250 µM) and ABT-737 (4-200 µM) for
48 hours, and cell death was determined. The data are mean ± standard deviation
of triplicate experiments. The experiments were performed independently three
times. (F) The data shown in (E) was evaluated as described in MATERIALS AND
METHODS and CI values were computed.
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3.3.4. Anti-apoptotic Bcl-2 proteins do not affect C12 cytotoxicity.
Anti-apoptotic Bcl-2 proteins are frequently overexpressed in human cancers and
associated with chemotherapeutic resistance and relapse (145). To investigate
the involvement of anti-apoptotic Bcl-2 proteins in C12-induced human tumor cell
apoptosis, Bcl-2, Mcl-1 and Bcl-xL were stably overexpressed in A549 cells
respectively by retroviral infection (Figures 3.4A, 3.5A and 3.5D). The anti-tumor
drug actinomycin D caused less cell death and caspase-3/7 activation in Bcl-2-,
Mcl-1- or Bcl-xL-overexpressing cells than in cells expressing the empty vector
(Figures 3.4B-C, 3.5B-C and 3.5E-F). In contrast, C12 induced similar levels of
cell death and caspase-3/7 activation in cells overexpressing Bcl-2, Mcl-1 or BclxL and the vector control cells (Figures 3.4B-C, 3.5B-C and 3.5E-F). To further
explore the involvement of Mcl-1 in mediating C12-induced cytotoxicity, we
examined A549 cells in which Mcl-1 expression was stably reduced by shRNA
(146). Actinomycin D but not C12 caused more cell death and caspase-3/7
activation in Mcl-1-knockdown cells than the cells expressing the control
scramble shRNA (Figures 3.5G-H), further validating that Mcl-1 expression is not
vital for C12-induced apoptotic signaling.

MOMP has been recognized to be a “no-return” step during mitochondria-based
apoptotic signaling (105). To further investigate C12-initiated apoptosis in tumor
cells, we studied the involvement of Bcl-2 in two key events of MOMP:
depolarization of mitochondrial membrane potential (∆mito) and cytochrome c
release. Depolarization of ∆mito was evaluated by determining the changes in
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fluorescence of the voltage-dependent dye JC1 released from mitochondria into
the cytosol and nucleus. Within minutes of C12 exposure, mitochondria in A549vector cells and A549-Bcl-2 overexpressing cells were depolarized to the same
degree (Figures 3.4D-E). Moreover, C12 caused cytochrome c release from
mitochondria in both A549-vector and Bcl-2 or Mcl-1 over-expressing A549 cells
(Figures 3.6 and 3.7). Taken together, these results indicate that overexpression
of anti-apoptotic Bcl-2 proteins reduces apoptosis in response to the classical
anti-tumor drug actinomycin D but fails to provide protection against C12.
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Figure 3.4. C12 induces tumor cell apoptosis independent of anti-apoptotic protein
Bcl-2.
(A) Retrovirally overexpressed Bcl-2 in A549 cells was examined by western blot.
(B) Cell viability was measured 48 hours after C12 or actinomycin D (ActD)
exposure. (C) Caspase-3/7 activities were determined following 2 hour exposure
to C12 and 24 hour exposure to actinomycin D. (D) C12’s effect on mitochondrial
membrane potential is independent of Bcl-2. A549-vector and A549-Bcl-2overexpressing cells were loaded with JC1, and its fluorescence was measured
using imaging microscopy during the treatment with 100 M C12 and 5 M FCCP.
Typical results from three independent experiments are shown. (E) C12 caused
equivalent depolarization of mitochondrial potential in vector and Bcl-2overexpressing A549 cells. All data are shown as mean ± standard deviation of
three independent experiments. Asterisks indicate P < 0.05 (*); ns, no significant
by student's unpaired t test.
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Figure 3.5. Anti-apoptotic Bcl-2 protein Mcl-1 and Bcl-xL do not affect C12
cytotoxicity.
(A)The expression levels of Mcl-1 in the indicated A549 cells were determined by
western blot. (B) Cell viability of the indicated A549 cells with or without Mcl-1
over-expression was measured 48 hours after the treatment. (C) Caspase-3/7
activities were determined after exposure to C12 for 2 hours and exposure to
actinomycin D for 24 hours. (D) Bcl-xL was stably overexpressed in A549 cells by
retroviral infection. (E) Cell death was measured after 48 hour-incubation of C12 or
actinomycin D (1 µg/ml) in A549 cells without or with over-expressed Bcl-xL. (F)
Caspase-3/7 activities were examined 32 hours after C12 or actinomycin D
exposure. (G) After treating A549 cells expressing Mcl-1 shRNA or control shRNA
with C12 or actinomycin D for 72 hours, cell death was measured. (H) Caspase3/7 activities were measured after 32 hour-incubation of C12 or actinomycin D in
the indicated A549 cells. All data are presented as mean ± standard deviation of
three different experiments that were carried out in triplicate. Asterisk indicates P <
0.05 (*) or P< 0.01 (**) by student’s unpaired t test. ns, no significant.
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Figure 3.6. C12-induced cytochrome c release in tumor cells is independent of
Bcl-2.
Upon C12 exposure, cytochrome c is released from mitochondria in both A549vector and A549-Bcl-2 over-expressing cells. Representative confocal images of
A549 cells treated with either DMSO (control) or 100 µM C12 for 3 hours.
Cytochrome c is shown in red, and DAPI is shown in blue. Following C12
treatment, staining of cytochrome c became diffuse. Scale bar, 10 µm.
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Figure 3.7. C12-induced cytochrome c release in tumor cells is independent of
Mcl-1.
After treating with 100 µM C12 of 3 hours, cytochrome c was released from
mitochondria in both A549-vector and A549-Mcl-1 over-expressing cells.
Representative images acquired by confocal microscopy are shown. Scale bar,
10 µm.
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3.3.5. C12 blocks tumor growth independent of Bcl-2 protein.
To determine whether anti-apoptotic Bcl-2 protein-independent C12 cytotoxicity
is relevant in vivo, we examined its effects on the growth of tumors originated
from A549 cells with different levels of Bcl-2 expression in athymic nude mice. As
shown in Figures 3.8A-B, A549-Bcl-2 overexpressing tumors grew much faster
than their vector control counterparts, which is consistent with the oncogenic
function of Bcl-2 (147). C12 inhibited the growth of vector control A549 tumors
and Bcl-2-overexpressing A549 tumors to a comparable degree. Inhibitory effects
of C12 on tumor growth are likely attributed to apoptosis, as more TUNELpositive cells were detected in C12-treated tumors than vehicle-treated ones
regardless of Bcl-2 expression levels (Figures 3.8C-D). Overall, these results
show that Bcl-2 is not involved in the cytotoxic effects of C12 in vitro as well as in
vivo.
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Figure 3.8. C12 inhibits tumor growth independent of Bcl-2.
(A-B) Growth of A549-vector (A) and A549-Bcl-2-overexpressing tumors (B) in
athymic nude mice treated with vehicle control or C12 (15 mg/kg/day). Data are
shown as mean ± standard deviation of tumor volumes of 8 animals in either
vehicle control (DMSO) or C12-treated groups. (C) Apoptotic cells in tumor
sections were identified by TUNEL assay. Representative images of tumor
sections from DMSO- and C12-treated mice are shown. Scale bar, 60 µm. (D)
Summary of the data shown in (C). More apoptotic cells were detected in tumors
of C12-treated mice than those of vehicle control mice. Mean ± standard deviation
of three independent tumor sections. For all the data, asterisk indicates P < 0.05
(*) by student’s unpaired t test.
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3.3.6. Bak and Bax are not involved in C12-induced apoptosis.
Previous studies show that C12 induces apoptosis in MEFs independent of Bak
and Bax (98, 114) , two pro-apoptotic Bcl-2 members required for MOMP in
almost all apoptotic paradigms (148). To clarify their role in C12-induced tumor
cell apoptosis, human colon carcinoma HCT116 cell lines lacking Bak alone, Bax
alone, or both Bak and Bax (Bak/Bax-DKO) were studied (Figure 3.9A). C12
caused roughly equivalent cell death and caspase-3/7 activation in all the
HCT116 cell lines examined, indicating that deficiency of Bak and Bax in
HCT116 cells did not influence their responses to C12 (Figures 3.9B-C). Unlike
C12, the therapeutic drug etoposide induced significant cell death and caspase3/7 activation in WT, Bax-KO and Bak-KO but not in Bak/Bax-DKO HCT116 cells
(Figure 3.10A-B). Moreover, deficiency in Bak/Bax expression did not affect
C12’s effect to depolarize ∆mito (Figures 3.9D-E) and release cytochrome c
(Figure 3.11), indicating Bak/Bax are not involved in C12- induced MOMP in
tumor cells. These results demonstrate that C12-induced apoptotic signaling is
distinct from that triggered by conventional anti-cancer drugs.
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Figure 3.9. C12-induced tumor cell apoptosis is independent of Bak and Bax.
(A) Bak and Bax expression in the indicated HCT116 cells was examined by
western blot. (B-C) C12 induced similar levels of cell death (B) and caspase-3/7
activation (C) among WT, Bak-KO, Bax-KO and Bak/Bax-DKO HCT116 cells after
24 hours treatment. (D) The mitochondrial potential of the WT and Bak/Bax-DKO
HCT116 cells loaded with JC1 was determined by fluorescent microscopy upon
the treatment with 50 M C12 and 5 M FCCP. Representative results are shown.
(E) Summary of the data shown in (D). All data are presented as mean ± standard
deviation of three different experiments. ns, no significant.
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Figure 3.10. Etoposide induces tumor cell death and inhibits xenografted tumor
growth dependent of Bak and Bax.
(A) Etoposide induced significant cell death in WT, Bak-KO and Bax-KO HCT116
cells but not in their Bak/Bax-DKO counterparts after 48 hours of treatment. (B)
Caspase-3/7 activities were examined 24 hours after etoposide exposure. All the
data are presented as mean ± standard deviation of three different experiments.
Asterisk indicates P < 0.05 (*) or P< 0.01 (**) by student’s unpaired t test. (C-D)
Growth of HCT116-WT tumors (C) and HCT116-Bak/Bax-DKO tumors (D) in
athymic nude mice treated with the vehicle control or etoposide. Data are mean ±
standard deviation of tumor volumes of five animals in each group.
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Figure 3.11. C12 triggered cytochrome c release in tumor cells independent of
Bak and Bax.
(A-B) Cytochrome c was released from mitochondria in both HCT116-WT (A) and
HCT116-Bax/Bak-DKO (B) cells upon treating with 100 µM C12 of 3 hours. Typical
confocal images are shown. Cytochrome c is shown in red, and DAPI is shown in
blue. Scale bar, 10 µm.
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3.3.7. The inhibitory effects of C12 on tumor growth are independent of Bak and
Bax.
To further investigate whether the Bax/Bak-independent effect of C12 to trigger
apoptosis in vitro also occurred in vivo, WT and Bax/Bak-DKO HCT116 cells were
inoculated into athymic nude mice. C12 reduced the growth of established
HCT116-WT tumors and HCT116-Bak/Bax-DKO tumors to a similar degree
(Figures 3.12A-B), indicating that Bak and Bax are not involved in anti-tumor
activity of C12. Moreover, the level of activated caspase-3 and the percentage of
TUNEL-positive cells were higher in C12-treated tumors than vehicle-treated
tumors regardless of Bak and Bax expression levels (Figures 3.12C-F), suggesting
that C12 inhibits tumor growth probably through inducing Bak/Bax-independent
apoptosis.
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Figure 3.12. C12 inhibits xenografted tumor growth independent of Bak and Bax.
(A-B) Growth of HCT116-WT tumors (A) and HCT116-Bak/Bax-DKO tumors (B) in
athymic nude mice treated with vehicle control or C12 (15 mg/kg/day). Data are
mean ± standard deviation of tumor volumes of 8 animals in each group. (C)
Apoptotic cells in tumor sections were detected by immunofluorescence staining of
activated caspase-3. Representative images of tumor sections from DMSO- and
C12-treated mice are shown. Scale bar, 50 µm. (D) The percentage of activated
caspase-3 shown in (C) were quantified. Data are mean ± standard deviation of
three independent tumor sections. Asterisk indicates P< 0.05 (*) or P< 0.01 (**) by
student's unpaired t test (E) Typical TUNEL labeling images of tumor sections
from vehicle control- and C12-treated mice are shown. Scale bar, 60 µm. (F) The
percentage of TUNEL-positive cells in tumors of C12-treated mice is higher than
that of control mice. All data are mean ± standard deviation of three independent
tumor sections. Asterisk indicates P < 0.05 (*) or P< 0.01 (**) by student’s
unpaired t test.
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3.3.8. BH-3 only proteins Noxa and Puma are not involved in C12-induced tumor
cell apoptosis.
BH3-only proteins are another class pro-apoptotic Bcl-2 proteins, which share
sequence homology only in the BH3 domain, including Noxa and Puma (149). To
further elucidate whether BH3-only proteins are involved in C12 cytotoxicity in
tumor cells, we investigated two HCT116 cell lines in which Noxa expression was
stably reduced by shRNA (Figure 3.13A) or Puma expression was eliminated
genetically (Figure 3.13E) (150, 151). C12 caused similar levels of cell death and
caspase-3/7 activation in HCT116 cell lines with reduced expression of Noxa or
Puma compared with their corresponding counterparts expressing normal levels of
Noxa or Puma (Figures 3.13B, 3.13D and 3.13F-G). In contrast, less cisplatininduced cytotoxicity was observed in HCT116 cells with decreased Noxa or Puma
expression (Figures 3.13C and 3.13F-G). Overall, our results suggest that BH3only proteins are not critical for C12-induced apoptotic signaling.
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Figure 3.13. C12-induced tumor cell apoptosis is independent of BH-3 only
proteins Noxa and Puma.
(A) Noxa expression was stably reduced in HCT116 cells by shRNA. (B)
Following 24 hours treatment of C12, similar levels of cell death were detected in
HCT116 cells expressing Noxa shRNA and their control counterparts. (C) Less
apoptosis was detected in HCT116 cells with reduced Noxa expression upon
treatment of cisplatin (50 mM). (D) Caspase-3/7activities were measured after 24
hour-incubation of C12 or cisplatin in the indicated HCT116 cells. (E) Puma
expression in the indicated HCT116 cells was examined by western blot. (F) Cell
death was measured after 24 hour-incubation of C12 or tunicamycin in Pumadeficient HCT116 cells or wild-type cells. (G) Caspase-3/7 activities were
examined 24 hours after C12 or etoposide exposure. All data are presented as
mean ± standard deviation of three different experiments. Asterisk indicates P <
0.05 (*) or P< 0.01 (**) by student’s unpaired t test. ns, no significant.
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DISCUSSION
Despite growing evidence that the bacterial quorum-sensing molecule C12
induces apoptosis in various types of human tumor cells (66, 69-71), the
relevance of C12 cytotoxicity to tumor growth in animals was unknown.
Importantly, knowledge about the mechanism of C12-evoked tumor cell
apoptosis has been limited. Here, we present the evidence that C12
preferentially triggers transformed cell apoptosis in vitro and inhibits transplanted
tumor growth in vivo as a single agent independent of both anti- and proapoptotic Bcl-2 proteins. Furthermore, selective cytotoxicity of C12 on lung tumor
cells and its inhibitory effects on tumor growth are likely related to upregulated
PON2 expression in the tumor cells.

Many neoplastic cells show an increased ratio of anti-apoptotic to pro-apoptotic
Bcl-2 proteins, which enables them to survive even under the conditions that
would normally initiate apoptotic signaling (121, 152). An emerging strategy for
cancer therapy is to overcome the resistance to apoptosis caused by aberrant
Bcl-2 signaling in tumor cells (153). Recently, several small molecules triggering
apoptosis independent of either pro- or anti-apoptotic Bcl-2 proteins have been
identified as potential anti-tumor drugs. Among them, the pentacyclic triterpenoid
betulinic acid induces Bax/Bak-independent MOMP and subsequent apoptosis
(154). Unlike C12, cytotoxic effects of betulinic acid are influenced by Bcl-2
overexpression and it is ineffective against epithelial tumors. Similarly, Bax/Bak is
also nonessential in apoptotic signaling induced by chelerythrine (155),
mitochondrial Kv1.3 channels inhibitors (156) or titanium dioxide (TiO2) (157).
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The polyphenolic compound gossypol evokes Bax/Bak-independent apoptosis
and inhibits Bcl-2-overexpressing tumor growth (158). Furthermore, Bcl-2
expression fails to influence human tumor cell apoptosis induced by the antibiotic
agent Tetrocarcin-A or protein complex HAMLET (128, 129). Compared with
those molecules, C12 is the first small molecule compound, to the best of our
knowledge, inducing human tumor cell apoptosis in vitro as well as blocking
tumor growth in vivo independent of both pro- and anti-apoptotic Bcl-2 proteins.

The apoptosis cascade induced by C12 in tumor cells is unique, evident by its
rapid pro-apoptotic effects, such as depolarizing mitochondrial membrane
potential within minutes (Figures 3.4 and 3.9), releasing cytochrome c into the
cytosol within three hours (Figures 3.7 and 3.11) and maximally activating
caspases within four hours (Figure 3.1). These distinctive pro-apoptotic features
of C12 have not been observed in any other apoptosis paradigms of cancer cells,
which might be attributed to the ability of C12 or its derivatives generated in
tumor cells to directly permeabilize mitochondria (within minutes) without the
involvement of pro- and anti-apoptotic Bcl-2 proteins.

As Pseudomonas aeruginosa produces C12 to control virulence factors, C12
alone could potentially promote infections, particularly in immune compromised
patients (159). Published information about the safety of C12 in vivo is limited
except that C12 exerts acute influence in immune responses in mice. For
instance, C12 reduces innate immune responses acutely via disrupting TLR4-
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dependent NF-B signaling in mice (62). In a murine model of dermal
inflammation, intradermal injection of C12-loaded micelles leads to local immune
cell infiltration within 24 hours (63). In our studies, administration of C12 for
extended periods of time does not appear to cause significant toxicity to either
normal or immunodeficient athymic nude mice (Figure 3.2), suggesting that longterm side effects of administrating C12 on animals might be limited.

Overall, our study reveals that C12 inhibits tumor growth in animals as a single
agent, through inducing a unique Bcl-2 protein-independent apoptotic cascade in
tumors. Therefore, C12 is an ideal candidate of a lead compound for novel
therapeutic agents for cancer.
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CHAPTER IV
PARAOXONASE 2 IS ESSENTIAL FOR THE PROLIFERATION OF
NON-SMALL CELL LUNG CANCER CELL
4.1 INTRODUCTION
Human cancer originates from abnormal accumulation of a clonal population of
somatic cells, which disrupts tissue homeostasis (121, 160). The initiation and
progression of cancer involves genetic changes resulting in alterations in tissue
development and homeostatic maintenance. Understanding how genetic
alterations regulate tumor cell proliferation is essential for successful prevention,
diagnosis and treatment of tumors.

Among the genes whose expression is altered in tumor cells is an enzyme
named paraoxonase 2 (PON2) (78, 79, 161-164). PON2 belongs to a highly
conserved gene family (PON1, 2, 3) with lactonase and arylesterase activities
(165-167). The three PON (1-3) genes are located in a cluster on human
chromosome 7 or mouse chromosome 6, and PON proteins share about 66% of
identity in amino acid sequences (168, 169). PON1 is secreted out of cells and
associated with high-density lipid protein (HDL) in the blood following secretion
(170). Like PON1, PON3 is also bound to HDL in the blood stream (171). In
contrast, PON2 is an intracellular enzyme (172). PON1 and PON3 are primarily
found in the liver, whereas PON2 is ubiquitously expressed in a number of
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tissues, including the liver, kidney, lung, heart, stomach, spleen, pancreas and
macrophages (173). The three PON proteins possess overlapping but distinct
enzymatic specificity (76, 174, 175). Among various substrates of PON proteins,
N-acyl-homoserine lactones are of special interest, since they are quorumsensing molecules for communication among pathogenic bacteria (59, 84, 176).
Growing evidence demonstrate that PON proteins, particularly PON2, modulate
many biological effects of N-acyl-homoserine lactones, such as triggering stress
signaling and apoptosis in host cells (74, 95, 177, 178). The hydrolysis of N-acylhomoserine lactones by PON2 is expected to reduce quorum sensing by the
bacteria and subsequently alleviate responses of host cells to N-acyl-homoserine
lactones.

In addition to its lactonase-esterase activity, PON2 also displays antioxidant
activity (72). The antioxidant activity may contribute to the ability of PON2 to
possess both anti-inflammatory and anti-apoptotic functions (72, 175) as well as
explain why PON2 is often upregulated in cancer (78, 79, 161-164). Normally
PON2 mutations that reduce its lactonase activity do not alter its antioxidant
activities, demonstrating that these two functions are mediated by different
aspects of PON2. However, the role of PON2 lactonase activity in mediating
apoptosis appears to be determined by the particular apoptosis signaling
pathways involved (138, 179). For instance, PON2 mutants lacking lactonase
activity seems to be more effective in preventing apoptosis in the Bax/Bakdependent canonical apoptotic signaling pathway than wild type PON2 (179). In
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contrast, PON2 uses its lactonase activity to promote a unique Bax/Bakindependent apoptosis in response to a homoserine lactone (138).

4.2 MATERIALS and METHODS
4.2.1. Reagents
N-(3-oxododecanoyl)-homoserine lactone (C12) and polybrene were acquired
from Sigma (St. Louis, MO). Propidium iodide (PI) was purchased from Invitrogen
(Carlsbad, CA). All reagents were dissolved in Dimethyl sulfoxide (DMSO).
Lipofectamine 2000® was obtained from Invitrogen. Antibodies (Ab) used for
western blot analysis were anti-β-actin mAb (Sigma), anti-human PON2 (Abcam;
Cambridge, MA), anti-mouse PON2 pAb (antibodies-online; Atlanta, GA), antiSDHA mAb (Cell signaling; Danvers, MA), peroxidase-conjugated goat anti-rabbit
IgG (Thermo; Waltham, MA), peroxidase-conjugated goat anti-mouse IgG
(Thermo), peroxidase-conjugated mouse anti-rabbit IgG (TrueBlot®, Rockland;
Limerick, PA), peroxidase-conjugated rat anti-mouse IgG (TrueBlot®, Rockland).

4.2.2. DNA plasmids
Murine PON2 cDNA was purchased from Origene (Rockville, MD) and
subsequently cloned into the lentiviral expression vector pCDH-CMV-MCS-EF1copGFP (System Biosciences; Palo Alto, CA) to generate the plasmid pCDHCMV-mPON2-EF1-copGFP with the green fluorescent protein (GFP) functioning
as an indicator of infection. The identity of the plasmids was validated by
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sequencing. Lentiviral shRNA plasmid for human PON2 and its counterpart with
scramble sequence were purchased from Santa Cruz (Dallas, TX).

4.2.3. Retrovirus and lentivirus production
For lentivirus production, the package cell line human embryonic kidney (HEK)293T was transfected with the plasmid pCDH-CMV-mPON2-EF1-copGFP,
human PON2 shRNA plasmid or their corresponding control plasmids along with
the helper plasmids pMDLg/pRRE, pRSV.Rev, and pMDG2.0 (Addgene;
Cambridge, MA) using the Lipofectamine 2000 ® transfection reagent. Medium
containing lentivirus was collected 48-72 hours following transfection.

4.2.4. Generation of cell lines and cell culture
Non small cell lung carcinoma cell lines A549 and NCI-H1299 were purchased
from ATCC (Bethesda, MD). HEK293T cells were also obtained from ATCC.
Human bronchial epithelial (HBE) cells immortalized by expressing hTERT and
Cdk4 were acquired from Professor Geoffrey Clark (University of Louisville). To
generate cells with reduced PON2 expression or empty vector control, A549,
NCI-H1299, HEK293T and HBE cells were infected with the medium containing
corresponding lentivirus and 10 µg/ml of polybrene to enhance infection
efficiency. Stable cell lines were generated by culturing cells in the medium
containing 2 g/ml puromycin. A549 and NCI-H1299 cells expressing murine
PON2 were generated by infection with the lentiviral supernatants containing 10
µg/ml of polybrene. Almost all of the infected cells (>95%) were GFP positive as
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evaluated by flow cytometry (FACScalibur, Beckon Dickinson; San Jose, CA).
All of cell lines were cultured in Dulbecco's Modified Eagle Medium (DMEM)
medium (Mediatech; Manassas, VA) supplemented with 10 % fetal bovine serum
(FBS) (Gemini; West Sacramento, CA), 100 U/ml penicillin (Mediatech), and100
µg/ml streptomycin (Mediatech) in an incubator with 95 % humidity and 5 % CO2
at 37oC.

4.2.5. Cell viability assay
The indicated cells were cultured in 48-well tissue culture plates with 1x104 cells
in each well 24 hours before treatment with apoptotic stimuli. At the indicated
time points following the treatment, cells were trypsinized and resuspended in
growth medium containing 1 µg/ml propidium iodide. Cell viability was evaluated
by a PI exclusion approach using flow cytometry (FACScalibur). The
experiments were performed in triplicates. The percentage of cell death is
calculated as 100 minus the percentage of viable cells. .

4.2.6. Cell cycle analysis and cell proliferation assay
For cell cycle analysis, 5 × 105 cells were sedimented (300 x g for 5 minutes) and
washed twice with 500 µl 1 x PBS. Cells were then fixed with 1 ml 70% ethanol
in 1 x PBS at 4oC overnight. After centrifugation (300 x g for 5 minutes), cells
were washed twice with 1 x PBS and resuspended in 500 µl 1 x PBS. 50 U
RNase A (Qiagen; Valencia, CA) were added to samples followed by incubation
at 37oC for 1 hour. Then propidium iodide (5 µg) was added to samples which
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were incubated for 30 minutes at 37oC before flow cytometric analysis
(FACScalibur). To evaluate cell proliferation, 1.5 × 104 cells were plated in wells
of a 12-well tissue culture plate and the number of the cells in each well was
determined using a hemocytometer.

4.2.7. Western blot analysis
Cell pellets were collected, and whole cell lysates were generated by
resuspending cells in RIPA lysis buffer (150 mM sodium chloride, 1% (v/v) Triton
X-100, 0.5% sodium deoxycholate, 0.1% sodium dodecyl sulphate, and 50 mM
Tris, pH 8.0) containing protease inhibitors (Complete, Roche; Indianapolis, IN).
To remove cell debris and nuclear materials, cells were first sonicated for 30
seconds at 10% amplitude (Sonic Dismembrator, Model 500, Fischer Scientific;
Hampton, NH) before centrifugation at 13,000 x rpm at 4oC for 10 minutes, and
the supernatant was collected. The protein concentration was determined using
the BCA Assay (Pierce; Rockford, IL). Thirty micrograms of protein sample were
loaded on a 4-12% Bis-Tris gel (Bio-Rad; Hercules, CA) and transferred to PVDF
(Millipore; Billerica, MA). The membrane filters were incubated in buffer
containing 1 x PBS, 0.2% (v/v) Tween 20, and 10% (w/v) nonfat dry milk
(BioRad) with appropriate primary antibodies at 4oC overnight or at 25oC for
about three hours. After three 10 minute wash with 1 x PBS/0.2% Tween
solution, the membrane filters were then incubated with the appropriate
peroxidase-coupled secondary antibodies at 4oC overnight or for at 25oC for
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three hours. Proteins were detected using the enhanced chemiluminescent
detection system (Thermo).

4.2.8. Lung tumor tissues from patients
Tumor tissues along with corresponding adjacent normal tissues from non small
cell lung carcinoma (NSCLC) patients were acquired from the James Graham
Brown Cancer Center Bio-Repository at University of Louisville following an
approved IRB protocol. Frozen tissue samples were resuspended in tissue
protein extraction reagent (Thermo Fisher) supplemented with protease inhibitors
(Complete, Roche; Indianapolis, IN) and phosphatase inhibitors (PhosSTOP,
Roche). Following homogenization and centrifugation, protein concentration was
determined by BCA assay (Thermo Fisher). Thirty micrograms of total protein
were electrophoresed in 4–12% Bis/Tris gels (Bio-Rad; Hercules, CA). PON2
was detected by western blot.

4.2.9. Immunoprecipitation
A549 cells (1 x 108) were collected and washed once with 1 x PBS. Cells were
resuspended in cell lysis buffer containing 12 mM HEPES (pH 7.5), 1.7 mM TrisHCl (pH 7.5), 100 mM KCl, 140 mM mannitol, 23 mM sucrose, 2 mM KH2PO4, 1
mM MgCl2, 0.67 mM EGTA, and 0.6 mM EDTA supplemented with protease
inhibitors (Complete; Roche Diagnostics, Indianapolis, IN). The cells were
broken open by a dounce homogenizer. The whole cell lysate was centrifuged
at 300 x g for 10 minutes at 4oC to remove large cellular debris and nuclei. The
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remaining supernatant was centrifuged at 10,000 x g for 10 minutes at 4˚C, and
the resulting mitochondria-enriched pellet was resuspended in mitochondrial lysis
buffer containing 50 mM Tris (pH7.5), 150 mM NaCl, 0.05% SDS, 1% NP-40 and
protease inhibitors. The mitochondrial lysate was acquired by passing through a
syringe with a needle (Gauge 30) 10 times to break open mitochondria.
Following centrifuged at 16,000 x g for 10 minutes at 4oC, the protein
concentration of the supernatant was determined by a BCA assay. Mitochondrial
lysate (4 mg) was incubated with 20 l anti-Rabbit Ig IP agarose beads (50%
slurry, TrueBlot®, Rockland; Limerick, PA) at 4oC for 30 minutes to preclear
nonspecific protein interaction. Precleared mitochondrial lysate was split into two
equal parts. One part was untouched and the other part was incubated with 5 l
anti-PON2 antibodies (Abcam) overnight at 4°C. Then anti-Rabbit Ig IP agarose
beads (50 μl of 50% bead slurry) were added to the mixture of protein lysate and
antibodies and incubated with gentle rocking for 3 hours at 4°C. Following
centrifugation at 16,000 x g for 2 minutes at 4oC, the beads were washed 3 times
with 500 μl of mitochondrial lysis buffer. The beads with bound proteins were
sent to the Genome Center at University of California, Davis for proteomic
analysis.

4.2.10. Proteome data analysis
The resulting. msf files from Proteome Discoverer were loaded into Scaffold Q+S
v4.3.2. Scaffold was used to calculate the false discovery rate using the peptide
and protein prophet algorithms. The results were annotated with mouse gene
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ontology information from the Gene Ontology Annotations Database. Heat maps
were compiled in the open-source statistical programming language R. Proteome
output as Log2 fold change of control was analyzed with the heatmap.2 function
of the gplots package, using the methods described by Key et al. Pearson’s
correlation coefficient was used to measure distance, and the Ward method
(ward.D) was the agglomeration method for row and column clustering.

4.2.11. Statistical analysis
Statistical analysis was performed using the student t-test and the two way
analysis of variance (ANOVA). A P value < 0.05 was considered significant.
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4.3 RESULTS
4.3.1. PON2 expression is enhanced in human lung tumor tissues and
oncogenically transformed HBE cells.

It has been shown that PON2 upregulation in some cancer cells, including lung
cancer cell lines, enables cancer cells to become resistant to conventional
therapeutic drugs (79). To determine whether PON2 expression is enhanced in
human lung cancer, we examined PON2 protein levels in tumor tissues of nonsmall cell lung carcinoma (NSCLC) patients by western blot. Among eleven
samples from patients, we found that PON2 was overexpressed in eight of lung
cancer tissues compared with corresponding adjacent normal tissues, whereas
its expression was slightly decreased in three of them (Figure 4.1A). As Rastransformed HBE displayed higher levels of apoptosis compared with their
untransformed counterparts upon C12 treatment (Figures 3.1A-B), PON2
expression was also increased in transformed HBE cells (Figure 4.1C). These
observations provide more evidence that oncogenic transformation enhances
PON2 expression.
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Figure 4.1. PON2 expression is enhanced in human lung tumor tissues and
oncogenically transformed HBE cells. (A) Expression of PON2 in NSCLC
tissue specimens and corresponding adjacent normal tissues from 11 patients
were evaluated by western blot. Samples 1-4, 6, 8, 9, 11 were from
adenocarcinoma patients, whereas samples 5, 7, 10 were from squamous cell
carcinoma patients. T, tumor; N, normal. (B) The intensities of bands in (A)
were quantified using ImageJ software (NIH). To normalize loading variation,
the relative levels of PON2 were calculated by dividing the PON2 value into the
corresponding value for actin. The data were shown as a ratio of PON2 levels
in a tumor tissue sample versus its corresponding normal tissue, and the value
bigger than 1 indicates that PON2 expression is increased in tumor tissues.
Differential expression of PON2 in tumor versus normal tissues is significant
with the value of “P” smaller than 0.01 as calculated by student’s paired t test.
(C) The expression of PON2 and PON3 in primary HBE cells and their
transformed counterparts was determined by western blot.
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4.3.2. PON2 blocks chemotherapeutic drug-triggered apoptosis in NSCLC
cells.
To examine the role of PON2 in NSCLC cells’ apoptotic responses, we
investigated the prospective involvement of endogenous PON2 in cytotoxicity of
chemotherapeutic drugs. We employed shRNA to stably reduce PON2
expression in human NSCLC cell lines A549 and NCI-H1299, and endogenous
PON2 levels were markedly decreased (Figures 4.2A and 4.2D). Increased cell
death and caspase-3/7 activation observed in PON2-deficient cells in response
to the conventional apoptotic stimuli actinomycin D (Figures 4.2B-4.2E-F). This
is in agreement with previous studies, and the anti-apoptotic effects of PON2 is
thought to be associated with anti-oxidant activities of PON2 (78, 79).
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Figure 4.2. PON2 blocks chemotherapeutic drug-triggered apoptosis.
(A) PON2 expression in A549 cells was stably reduced by shRNA, and PON2
expression was determined by western blot. (B) The viability of A549 was
measured 32 hours after ActD treatment. (C) ActD induced less cell death in
A549 cells with reduced PON2 expression than control vector cells 48 hours
after treatment. (D) Stable reduction of PON2 expression in NCI-H1299 cells
was evaluated by western blot. (E) NCI-H1299 cell viability was assessed 24
hours following ActD exposure. (F) Less apoptosis was detected in NCI-H1299
cells with reduced PON2 expression upon ActD treatment for 24 hours. “ActD”;
actinomycin D. All data shown are mean ± standard deviation of three
independent experiments. Asterisks indicate P values of ˂ 0.05 (*) by
Student’s unpaired t test.
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4.3.3. PON2 is required in C12 cytotoxicity in human NSCLC cells.
Overexpression of PON2 promotes cytotoxicity of C12 in non-transformed MEF
and HEK293T cells (138), but the role of endogenous PON2 in C12-induced
apoptotic signaling is unclear. To further explore the mechanism of C12triggered apoptosis, we investigated the prospective involvement of endogenous
PON2 in C12 cytotoxicity in NSCLC cells. Treatment with C12 elicited less cell
death and caspase-3/7 activation in A549 and NCI-H1299 cells lacking PON2
expression (Figure 4.3). The distinct roles of PON2 in apoptosis of NSCLC cells
induced by C12 and therapeutic drugs provide more evidence that a novel form
of apoptosis is triggered by C12 (Figure 2.10).
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Figure 4.3. PON2 is required in C12’s cytotoxicity on NSCLC cells
(A) C12 induced less cell death in A549 cells with reduced PON2 expression
than control vector cells 32 hours after treatment. (B) Upon treatment with
different doses of C12 for 32 hours, less caspase-3/7 activation was detected
in cells with reduced PON2 expression. (C) C12 induced less cell death in
NCI-H1299 cells with reduced PON2 following 24-hour treatment. (D) Less
apoptosis was detected in NCI-H1299 cells with reduced PON2 expression
upon C12 treatment. All data shown are mean ± standard deviation of three
independent experiments. Asterisks indicate P values of ˂ 0.05 (*) or ˂ 0.01
(**) by Student’s unpaired t test.
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4.3.4. Murine PON2 sensitizes human lung tumor cells with reduced
endogenous PON2 expression to C12.
To validate the role of PON2 in mediating C12-induced apoptosis, we stably
overexpressed murine PON2 cDNA in A549 cells deficient in PON2 expression
by retroviral infection (Figure 4.4A). Upon treatment with C12, we observed
more cell death and caspase-3/7 activation in PON2-deficient A549 cells
overexpressing murine PON2 compared to vector control and parental cells
(Figure 4.4B). Similarly, stable overexpression of murine PON3 in PON2knockdown NCI-H1299 cells was confirmed by western blot (Figure 4.4C). We
found that C12 induced more cell death and elicited higher caspase-3/7
activation in PON2-knockdown NCI-H1299 cells expressing mouse (Figure
4.4D).
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Figure 4.4. Murine PON2 sensitizes human lung tumor cells with reduced endogenous
PON2 expression to C12. (A) Murine PON2 cDNA was stably overexpressed in A549
cells with reduced PON2 expression by retroviral infection. Expression levels of PON2
were determined by western blot. (B) After treating with different doses of C12 for 24
hours, more cell death were detected in PON2-knockdown A549 cells with increased
mouse PON2 expression comparing to vector control and parental cells. (C) Stable
overexpression of murine PON3 in PON2-knockdown NCI-H1299 cells was examined
by western blot. (D) C12 induced more cell death in PON2-knockdown NCI-H1299
cells expressing mouse PON2 after 24 hours treatment. All data shown are mean ±
standard deviation of three independent experiments. Asterisks indicate P values of ˂
0.05 (*) by Student’s unpaired t test.

143

4.3.5. PON2 is essential for C12-triggered cell death in HEK-293T and HBE
cells.
To further explore the involvement of PON2 in apoptotic signaling in nontransformed cells, endogenous PON2 expression was stably reduced in
Human Embryonic Kidney-293T (HEK-293T) cells, whose viability was
assessed upon treatment with C12 (Figures 4.5A-B). Reducing PON2
expression in HEK-293 cells enabled cells resistant to C12. Furthermore, we
stably decreased PON2 expression in immortalized human bronchial epithelial
(HBE) cells (180) and measured cell viability upon C12 exposure (Figures
4.5C-D). Reducing PON2 expression in HBE cells de-sensitized cells to C12.
Overall, these data provide evidence that PON2 plays a similar role in
apoptotic signaling in both transformed and non-transformed cells.
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Figure 4.5. PON2 is essential for C12-triggered cell death in HEK-293T and
HBE cells. (A) PON2 expression was stably reduced in HEK-293Tcells. (B)
The viability of HEK-293Tcells was measured 24 hours after C12 treatment.
(C) Stable decrease of PON2 expression in human bronchial epithelial (HBE)
cells was determined by western blot. (D)The viability of HBE was evaluated 24
hours following C12 exposure. Mean ± standard deviation for three
independent experiments are shown. For all the data, *, P < 0.05, Student’s
unpaired t test.
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4.3.6. PON2 is essential for human lung tumor cell proliferation but not nontransformed cell proliferation.
During the process of generating A549 and NCI-H1299 cells lacking PON2
expression, we observed that those cells proliferated much slower than their
vector control counterparts. To determine whether or not PON2 is essential for
human lung tumor cell proliferation, we measured the proliferation of A549 cells
and NCI-H1299 expressing PON2 shRNA or the empty vector control. We
found that proliferation of NCI-H1299 and A549 cells with reduced PON2
expression was slower compared to that of their empty vector expressing
counterparts (Figure 4.6A-B), implicating a role of PON2 in lung tumor cell
proliferation. To determine whether or not PON2 is involved in the proliferation
of non-transformed cells, we measured the proliferation of HEK-293T and HBE
expressing PON2 shRNA or the empty vector control. It was found that HEK293T and HBE cells lacking PON2 expression grew at the same rate as their
counterparts expressing the empty vector (Figure 4.6C-D), indicating that
PON2 is not involved in non-transformed cell proliferation. Overall, these data
indicate that PON2 mediates apoptosis independently of its function to
modulate cell proliferation.
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Figure 4.6. PON2 is essential for human lung tumor cell proliferation but not
non-transformed cell proliferation. The proliferation of A549 cells (A), NCIH1299 cells (B), HEK-293T cells (C) and HBE cells (D) expressing PON2
shRNA or the empty vector control was measured. Proliferation of NCI-H1299
and A549 cells with reduced PON2 expression was slower compared with their
counterparts expressing the empty vector. HEK-293T cells (C) and HBE cells
with reduced PON2 expression proliferated at the same rate as their vector
control counterparts. All data shown are mean ± standard deviation of three
independent experiments. Asterisks indicate P values of ˂ 0.05 (*) by
Student’s unpaired t test.
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4.3.7. Deficiency in PON2 expression induces G1 cell cycle arrest of A549
cells.
To investigate the effects of deficient PON2 expression, we performed cell
cycle analysis to determine the cell cycle profile of A549 cells expressing
PON2 shRNA or the empty vector. We found that deficiency in PON2
expression induces cell cycle arrest at G1 phase in A549 cells (Figure 4.7).
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Figure 4.7. Deficiency in PON2 expression induces G1 cell cycle arrest of A549
cells. (A) Cell cycle profiles of A549 cells expressing PON2 shRNA or the
empty vector control were determined. (B) Summary of the data shown in (A).
Reducing PON2 expression caused higher percentage of the cells in G1 phase
of cell cycle. All data shown are mean ± standard deviation of three
independent experiments. Asterisks indicate P values of ˂ 0.01 (**) by
Student’s unpaired t test. “ns”, no significance.
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4.3.8. PON2 interacts with components of mitochondrial electron transport chain.
Since PON2 is known to be localized on mitochondrial inner membrane and
probably cleave oxidized mitochondrial lipids (73, 181), we carried out a
proteomics study to identify mitochondrial proteins associated with PON2 (Figure
4.8A). Mitochondria were isolated from A549 cells by a biochemical fractionation
approach, and proteins bound to PON2 were acquired by immunoprecipitation
using antibodies against PON2. Twelve mitochondrial proteins were discovered
in protein complexes containing PON2, and several potential PON2-binding
proteins are components of mitochondrial electron transport chain. Among them,
a component of Complex II, succinate dehydrogenase complex flavoprotein
subunit A (SDHA), displayed highest specific binding to PON2 (Figure 4.8B-C).
These data suggest that PON2 interacts with components of mitochondrial
electron transport chain in NSCLC cells.
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Figure 4.8. PON2 interacts with components of mitochondrial electron transport
chain. (A) The depiction of immunoprecipitation study to identify mitochondrial
proteins associated with PON2. (B) Twelve mitochondrial proteins were found in
protein complexes containing PON2. (C) Relative abundance of PON2 and
SDHA was evaluated by calculating normalized total TIC in a proteomics study.
(D) The binding between PON2 and SDHA was detected by immunoprecipitation.
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4.4 DISCUSSION
Despite recent progress, the detailed mechanisms underlying the initiation and
development of non-small NSCLC are still missing. Understanding of these
mechanisms is essential for successful prevention, diagnosis and treatment of
NSCLC. Here we report that PON2 is overexpressed in tumor tissues of NSCLC
patients compared with corresponding adjacent normal tissues. Importantly,
enhanced PON2 expression in NSCLC cells is essential for their proliferation, as
reducing PON2 expression in NSCLC cells results in cell cycle arrest at the G1
phase and markedly slower proliferation. It is conceivable that enhanced PON2
expression in NSCLC cells sustain rapid cell proliferation, probably by influencing
mitochondrial bioenergetics. Previous research of PON2 expression in tumor
cells largely focuses on its effects on conferring resistance to chemotherapeutic
drugs (78, 79, 95). Our data for the first time demonstrate a critical role of PON2
in NSCLC cell proliferation.

As a lactonase/arylesterase with anti-oxidant properties, PON2 expression is
elevated under a variety of physiological and pathological conditions. In mouse
peritoneal macrophages, oxidative stress promotes PON2 expression at both
mRNA and protein levels, but decreases PON3 expression (182). Similarly,
enhanced reactive oxygen species (ROS) production in vascular cells evokes
oxidative stress, which in turn elevates PON2 expression (183). During
monocytes differentiation into macrophages, PON2 expression is increased
through a mechanism dependent on activating nicotinamide-adenine-
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dinucleotide-phosphate (NADPH)-oxidase, which is partially modulated by the
transcription factor AP-1 (184). A common theme arisen from these studies is
that PON2 expression increase may represent a compensatory signaling
cascade against the enhanced cellular oxidative stress, which is in agreement
with the well-established anti-oxidative activity of PON2 (73, 78, 179, 181, 183,
185).

The level of oxidative stress within cells greatly influences many important
cellular functions of mammalian cells (186). Emerging evidence supports the
idea that a persistent and excessive production of intracellular ROS is involved in
the initiation and progression of cancer (187-189). ROS function as cellular
messengers in signaling cascades of cancer cells to initiate tumorigenesis and
promote tumor development, consistent with their activity to evoke DNA damage
and subsequent tumorigenic genetic mutations. Therefore, it is conceivable that
PON2 expression may be elevated in cancer cells with high levels of oxidative
stress to provide protection against ROS-induced damages. Indeed, enhanced
PON2 mRNA levels have been observed in a variety of tumors through
microarray studies (161-164). Subsequent experiments using tumor samples
combined from patients or healthy people further validate the increased PON2
expression at the protein levels in some of those tumors (78). In this study, we
directly compare PON2 expression at protein level in human NSCLC tumor
tissues with neighboring normal tissues from the same patient (Figure 4.1). Our
data provide unequivocal evidence that PON2 are overexpressed in NSCLC,
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which is critical for NSCLC cell proliferation but not for their untransformed
counterparts (Figure 4.6). Although the signaling pathway utilized by NSCLC
cells to achieve an increase in PON2 expression is still unclear, the underlying
mechanisms is likely associated with elevated oxidative stress in cancer cells.

Rapidly proliferating tumor cells is known to consume high levels of glucose and
produce lactate as major glucose-derived carbon in the presence of oxygen
(termed the Warburg effect), which was originally thought to be caused by
irreversible damages to mitochondrial oxidative metabolism and a subsequent
compensatory increase in glycolysis (190). However, many highly proliferating
tumor cells do not exhibit dysfunction in mitochondrial oxidative metabolism after
careful studies (191, 192). Furthermore, oncogenic transformation of human
mesenchymal stem cells promotes mitochondrial bioenergetics (193), and
mitochondrial metabolism is essential for Kras-evoked tumor cell proliferation and
tumorigenesis (194, 195). These findings demonstrate a critical role of
mitochondrial oxidative metabolism in tumor cell proliferation. The observation of
reduced electron transport chain activities and oxygen consumption in PON2deficient mice provides evidence that PON2 plays a critical role in maintaining
mitochondrial respiratory chain (73, 196). Thus, a possible scenario is that
overexpressed PON2 functions in NSCLC cells to promote mitochondrial
oxidative metabolism to meet the metabolic demand for rapid proliferation of
cells.
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Our proteomics studies demonstrate that PON2 likely interacts with components
of mitochondrial electron transport chain (Figure 4.8). Among them, SDHA, a
component of Complex II, displayed highest specific binding to PON2. In
addition, PON2 also interacts with several subunits of the water-soluble catalytic
sector (F1) of adenosine triphosphate (ATP) (Figure 4.8). Currently it remains
unknown which component of electron transport chain functionally interacts with
PON2, but our study clearly reveals an important function of PON2 in NSCLC cell
proliferation. Future studies will focus on elucidating the detailed molecular
mechanism of PON2 enhancing NSCLC cell proliferation.
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CHAPTER V
CONCLUSION AND FUTURE DIRECTIONS

5.1. Summary and Conclusions
Pseudomonas aeruginosa produces N-(3-oxododecanoyl)-homoserine lactone
(C12) as a quorum-sensing molecule for bacteria-bacteria communication. C12 is
known to influence many aspects of human host cell physiology, including
induction of cell death. Further to this, C12 has been reported to induce
apoptosis in various types of tumor cells. However, the detailed molecular
mechanism of C12-triggerred tumor cell apoptosis remains unclear. Additionally,
it is completely unknown whether C12 possesses any potential therapeutic
effects in vivo. To clarify cell death signaling induced by C12, we examined
mouse embryonic fibroblasts (MEFs) deficient in “initiator” caspases or “effector”
caspases. Our data has indicated that C12 selectively induces the mitochondriadependent intrinsic apoptotic pathway by quickly triggering mitochondrial outer
membrane permeabilization (MOMP). Importantly, the activities of C12 to
permeabilize mitochondria is independent of activation of both “initiator” and
“effector” caspases. Furthermore, C12 directly induces MOMP in vitro. Our
studies have also indicated that, unlike most apoptotic inducers, C12 evokes a
novel form of apoptosis in tumor cells independent of both pro- and anti-apoptotic
Bcl-2 proteins. We have also determined that C12 inhibits tumor
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growth in animals regardless of either pro- or anti-apoptotic Bcl-2 proteins.
Furthermore, we have demonstrated that unlike conventional chemotherapeutics,
C12 requires paraoxonase 2 (PON2), a lactonase/arylesterase with anti-oxidant
properties, to exert its cytotoxicity on tumor cells. Our recent studies have found
that PON2 is overexpressed in tumor tissues of non-small cell lung cancer
(NSCLC) patients compared with corresponding adjacent normal tissues.
Importantly, enhanced PON2 expression in NSCLC cells is essential for their
proliferation, as reducing PON2 expression in NSCLC cells results in cell cycle
arrest at the G1 phase and markedly slower proliferation. In contrast, altering
PON2 expression fails to influence the proliferation of untransformed human
epithelial cells, including bronchial epithelial cells. Using proteomics and
biochemical approaches, we have shown that PON2 in NSCLC cells specifically
interacts with succinate dehydrogenase complex flavoprotein subunit A (SDHA),
a component of Complex II of mitochondrial electron transport chain. Overall,
our studies have discovered a mitochondrial apoptotic-signaling pathway
triggered by C12, in which C12 or its metabolite(s) acts to permeabilize
mitochondria, leading to activation of apoptosis. Moreover, our results
demonstrate that C12 inhibits tumor growth independent of both pro- and antiapoptotic Bcl-2 proteins via the induction of unique apoptotic-signaling mediated
by PON2 in tumor cells. Enhanced PON2 expression in NSCLC cells might
promote mitochondrial bioenergetics to sustain the rapid proliferation of NSCLC
cells.
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5.2. Future Perspectives
We will investigate the mechanism of apoptosis mediated by PON2/C12
interaction. C12 is preferentially toxic to cells expressing PON2. PON2 is known
to function as a lactonase to cleave C12. We postulate that PON2 hydrolyzes
C12 in cells, generating a pro-apoptotic molecule to induce Bcl-2 proteinindependent apoptosis.

We will also Investigate the mechanism of PON2 in modulating lung tumor cell
proliferation.PON2 is overexpressed in tumor tissues from NSCLC patients.
PON2 expression is important for the proliferation of NSCLC cells but not for their
untransformed counterparts. Therefore, we propose that enhanced PON2
expression in NSCLC cells promotes mitochondrial bioenergetics which
subsequently generates enough ATP and metabolites to sustain the rapid
NSCLC cell proliferation.
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APPENDIX: LIST OF ABBREVIATIONS
5-FU

5-Fluorouracil

Apaf-1

Apoptotic Protease Factor 1

BH

Bcl-2 homolog

C12

N-(3-oxododecanoyl)-homoserine lactone

COQ10

Coenzyme Q10

DISC

Death Inducing Signaling Complex

FADD

Fas Associated Death Domain

FasL

Fas Ligand

FBS

Fetal Bovine Serum

IAPs

Inhibitor of Apoptosis Proteins

LLC

Lewis Lung Carcinoma

MEFs

Mouse Embryonic Fibroblasts

MIPs

Maximum Intensity Projections

MOMP

Mitochondrial Outer Membrane Permeabilization

NHBE

Human Bronchi/Tracheal Epithelial Cells

NSCLC

Non-Small Cell Lung Carcinoma
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OMM

Outer Mitochondrial Membrane

PBS

Phosphate Buffered Saline

PI

Propidium Iodide

PON2

Paraoxonase 2

ROIS

Regions of Interest

TLR4

Toll-Like Receptor 4

TNF

Tumor Necrosis Factor

TNFR

Tumor Necrosis Factor Receptor

TNFR1

Tumor Necrosis Factor Receptor 1

TRAIL

TNF-Related Apoptosis Inducing Ligand

WT

Wild Type
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